Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Neurotransmitter Receptors and Postsynaptic Signal Transmission	53/204	1.5458174573185253E-62	1.2196499738243165E-59	0	0	51.11763551631101	7275.303309989201	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;GRIK2;PRKAG3;RPS6KA3;TUBB1;CHRNB4;PRKAB2;CHRNB3;PDPK1;HTR3C;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CHRNA1;GRIA1;CHRNA3;PRKAA1;CHRNA2;PRKAA2;CHRNA5;CHRNA7;CHRNA6;CHRNA9;GLRA1;GRIN2A;GLRA2;CACNG2;KCNJ3;MAPK3;GABRA2;GABRQ;GABBR2;GABRA1;KCNJ5;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A
Transmission Across Chemical Synapses	57/269	7.666465537373726E-62	3.024420654493935E-59	0	0	40.22756733400547	5660.960856456919	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;GRIK2;PRKAG3;SLC6A3;SLC6A4;RPS6KA3;TUBB1;CHRNB4;PRKAB2;CHRNB3;PDPK1;HTR3C;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CACNB1;CHRNA1;GRIA1;CHRNA3;PRKAA1;CHRNA2;PRKAA2;CHRNA5;CHRNA7;CHRNA6;CACNA1B;CHRNA9;GLRA1;GRIN2A;GLRA2;CACNG2;KCNJ3;MAPK3;GABRA2;GABRQ;GABBR2;GABRA1;KCNJ5;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A
Neuronal System	64/411	1.0625616819349537E-60	2.7945372234889283E-58	0	0	28.95231012364042	3998.1525583175085	GABRB3;GABRB2;GABRB1;PRKAG1;PRKAG2;GRIK2;PRKAG3;SLC6A3;SLC6A4;RPS6KA3;TUBB1;KCNH2;CHRNB4;PRKAB2;CHRNB3;KCND2;KCND3;PDPK1;HTR3C;HTR3D;HTR3B;GABRG3;PRKAB1;GABRG2;CACNB1;KCNQ2;KCNMA1;KCNQ3;CHRNA1;GRIA1;CHRNA3;PRKAA1;CHRNA2;PRKAA2;CHRNA5;CHRNA7;CHRNA6;CACNA1B;CHRNA9;GLRA1;GRIN2A;GLRA2;CACNG2;KCNJ1;KCNJ3;MAPK3;GABRA2;GABRQ;GABBR2;GABRA1;KCNJ5;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GRIN2C;GRIN2B;GRIN2D;GRIN1;GRIN3B;GRIN3A
Amine Ligand-Binding Receptors	21/43	7.601093142741486E-32	1.499315622405758E-29	0	0	113.11649428415896	8105.298023819684	CHRM2;CHRM3;CHRM1;CHRM4;CHRM5;HTR1D;HTR2B;HTR1A;HTR2C;HTR1B;ADRA1D;HTR2A;ADRA1B;ADRA1A;HRH1;HTR6;HTR7;ADRB3;HRH2;HRH4;DRD2
Class A 1 (Rhodopsin-like Receptors)	33/333	2.66371484099316E-24	4.2033420190872067E-22	0	0	13.847225806451613	751.6595496297028	CHRM2;OPRD1;PTGER4;CHRM3;CHRM1;PTGDR2;PTGER1;CHRM4;PTGER2;CHRM5;PTGER3;HTR2B;HTR2C;CXCR4;ADRA1D;HTR2A;ADRA1B;ADRA1A;EDNRA;HTR6;HRH1;HTR7;HRH2;HRH4;DRD2;HTR1D;HTR1A;HTR1B;TACR3;OPRM1;POMC;ADRB3;PNOC
Signal Transduction	79/2613	4.767912586829018E-23	6.2698050516801585E-21	0	0	4.941826028399094	253.99774318356518	CHRM2;GABRB3;CHRM3;GABRB2;GABRB1;CHRM1;PTGDR2;CHRM4;CHRM5;HTR2B;PRKAG1;HTR2C;PRKAG2;PLAT;ADRA1D;HTR2A;FGF1;NR3C1;ADRA1B;FGF2;TNF;ADRA1A;PRKAG3;FGF4;IKBKB;RPS6KA3;EDNRA;HTR6;HTR7;C1QBP;TUBB1;PDE4A;PRKAB2;PDPK1;TACR3;OPRM1;GABRG3;PRKAB1;GABRG2;ADRB3;PGR;PPARG;TP53;CFTR;PPARD;OPRD1;PTGER4;PRKAA1;PRKAA2;PTGER1;PTGER2;PTGER3;CXCR4;HRH1;HRH2;HRH4;DRD2;MAPK3;GABRQ;NTRK1;GABBR2;GABRA1;NTRK2;GABBR1;HTR1D;HTR1A;AKR1C3;HTR1B;MAPK14;ESR1;GRIN2B;NFKB1;GRIN2D;GRIN1;NFKBIA;POMC;PNOC;BCL2;PDE3A
GABA Receptor Activation	18/60	9.388811680698849E-23	1.0582532022959132E-20	0	0	49.84033613445378	2527.898778835329	GABRB3;GABRA2;GABRQ;GABRB2;GABBR2;GABRA1;KCNJ5;GABRB1;GABBR1;KCNJ6;GABRA6;GABRA5;KCNJ9;GABRA4;GABRA3;GABRG3;GABRG2;KCNJ3
GPCR Ligand Binding	35/467	1.0787209470592293E-21	1.0638885340371649E-19	0	0	10.262345679012345	495.4507679481471	CHRM2;OPRD1;PTGER4;CHRM3;CHRM1;PTGDR2;PTGER1;CHRM4;PTGER2;CHRM5;PTGER3;HTR2B;HTR2C;CXCR4;ADRA1D;HTR2A;ADRA1B;ADRA1A;EDNRA;HTR6;HRH1;HTR7;HRH2;HRH4;DRD2;GABBR2;GABBR1;HTR1D;HTR1A;HTR1B;TACR3;OPRM1;POMC;ADRB3;PNOC
Activation of NMDA Receptors and Postsynaptic Events	19/93	1.9192354919762688E-20	1.6825297812991958E-18	0	0	29.98736606428914	1361.419670194155	GRIA1;PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;GRIN2C;PRKAB1;GRIN2B;PRKAG3;GRIN1;GRIN2D;RPS6KA3;GRIN2A;GRIN3B;GRIN3A;TUBB1;MAPK3
Signaling by GPCR	40/706	2.6206754751822718E-20	2.0677129499188126E-18	0	0	7.769661553445337	350.3205960686074	CHRM2;OPRD1;PTGER4;CHRM3;CHRM1;PTGDR2;PTGER1;CHRM4;PTGER2;CHRM5;PTGER3;HTR2B;HTR2C;CXCR4;ADRA1D;HTR2A;ADRA1B;ADRA1A;RPS6KA3;EDNRA;HTR6;HRH1;HTR7;HRH2;HRH4;PDE4A;DRD2;MAPK3;GABBR2;GABBR1;PDPK1;HTR1D;HTR1A;HTR1B;TACR3;OPRM1;POMC;ADRB3;PNOC;PDE3A
GPCR Downstream Signalling	38/633	3.700142545047994E-20	2.654011334584425E-18	0	0	8.182028011204482	366.09118359063547	CHRM2;OPRD1;PTGER4;CHRM3;CHRM1;PTGDR2;PTGER1;CHRM4;PTGER2;CHRM5;PTGER3;HTR2B;HTR2C;CXCR4;ADRA1D;HTR2A;ADRA1B;ADRA1A;RPS6KA3;EDNRA;HTR6;HRH1;HTR7;HRH2;HRH4;PDE4A;MAPK3;GABBR2;GABBR1;PDPK1;HTR1D;HTR1B;TACR3;OPRM1;POMC;ADRB3;PNOC;PDE3A
Post NMDA Receptor Activation Events	17/80	1.0144528567914057E-18	6.670027533403492E-17	0	0	31.16429963798385	1291.2049427336947	GRIA1;PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;GRIN2C;PRKAB1;GRIN2B;PRKAG3;GRIN1;GRIN2D;RPS6KA3;GRIN2A;TUBB1;MAPK3
Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors	9/11	2.555757935252001E-17	1.5511484699337144E-15	0	0	498.01675977653633	19027.027998467132	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA7;CHRNA6;CHRNA9
Acetylcholine Binding and Downstream Events	9/14	9.081005133893997E-16	4.776608700428242E-14	0	0	199.17653631284915	6898.5145105391975	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA7;CHRNA6;CHRNA9
Postsynaptic Nicotinic Acetylcholine Receptors	9/14	9.081005133893997E-16	4.776608700428242E-14	0	0	199.17653631284915	6898.5145105391975	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA7;CHRNA6;CHRNA9
Serotonin Receptors	8/12	2.5148677815111492E-14	1.2401441747576855E-12	0	0	220.0888888888889	6891.857099871607	HTR6;HTR7;HTR1D;HTR1A;HTR2B;HTR1B;HTR2C;HTR2A
Highly Calcium Permeable Nicotinic Acetylcholine Receptors	7/9	2.053470211666561E-13	9.530517629440686E-12	0	0	383.0662983425414	11190.927593019262	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA6
Activation of PPARGC1A (PGC-1alpha) by Phosphorylation	7/10	6.790908083928818E-13	2.976681376788799E-11	0	0	255.3646408839779	7154.8120082966525	PRKAB2;PRKAA2;PRKAG1;PRKAG2;MAPK14;PRKAB1;PRKAG3
Presynaptic Nicotinic Acetylcholine Receptors	7/12	4.411504351029495E-12	1.8319352278748798E-10	0	0	153.20331491712707	4005.7772559446457	CHRNA1;CHRNA3;CHRNB4;CHRNA2;CHRNB3;CHRNA5;CHRNA6
Potassium Channels	13/103	1.5077335633985705E-11	5.948008907607361E-10	0	0	16.27847619047619	405.62427715887384	KCNH2;GABBR2;KCNJ5;GABBR1;KCNJ6;KCND2;KCND3;KCNJ9;KCNQ2;KCNMA1;KCNQ3;KCNJ1;KCNJ3
Lipophagy	6/9	5.224654529399121E-11	1.9629773446170983E-9	0	0	217.6813186813187	5153.615526129699	PRKAB2;PRKAA2;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Muscarinic Acetylcholine Receptors	5/5	6.957542291704676E-11	2.495227667343177E-9	0	0	99060.0	2316875.679849572	CHRM2;CHRM3;CHRM1;CHRM4;CHRM5
Activation of AMPK Downstream of NMDARs	8/28	1.3890002550147857E-10	4.7648747878550685E-9	0	0	43.98222222222222	998.2762270699358	PRKAA1;PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Interleukin-4 and Interleukin-13 Signaling	12/112	6.515667444454109E-10	2.1420256723642883E-8	0	0	13.44	284.2780587664523	OPRD1;POMC;VCAM1;IL1B;ALOX5;BCL2;OPRM1;PTGS2;FGF2;TNF;TP53;ICAM1
G Alpha (Q) Signalling Events	15/219	2.5373853149609757E-9	8.007988054016838E-8	0	0	8.33390003400204	164.9456469615501	CHRM3;CHRM1;PTGER1;CHRM5;HTR2B;HTR2C;TACR3;ADRA1D;HTR2A;ADRA1B;ADRA1A;RPS6KA3;EDNRA;HRH1;MAPK3
Signaling by ERBB4	9/58	3.3859809524631662E-9	1.0275149890359378E-7	0	0	20.278987572682706	395.51371178276366	GABRB3;GABRQ;GABRB2;GABRA1;GABRB1;PGR;GABRG3;ESR1;GABRG2
Assembly and Cell Surface Presentation of NMDA Receptors	8/43	5.746033808719898E-9	1.679118768548148E-7	0	0	25.113650793650795	476.5253958912849	GRIN2A;GRIN3B;GRIN3A;TUBB1;GRIN2C;GRIN2B;GRIN1;GRIN2D
Energy Dependent Regulation of mTOR by LKB1-AMPK	7/29	7.596586133317362E-9	2.140609449709785E-7	0	0	34.789050728277246	650.4010247059325	PRKAA1;PRKAB2;PRKAA2;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Prostanoid Ligand Receptors	5/9	8.502983082853685E-9	2.3133978111626062E-7	0	0	135.30054644808743	2514.269595050237	PTGER4;PTGDR2;PTGER1;PTGER2;PTGER3
Signaling by Interleukins	20/452	1.0609876036410248E-8	2.7903973975758955E-7	0	0	5.340608465608466	98.06147856280506	OPRD1;VCAM1;OPRM1;PTGS2;MAPK14;FGF2;TNF;NFKB1;ICAM1;NFKB2;NFKBIA;IKBKB;POMC;RPS6KA3;CA1;IL1B;ALOX5;BCL2;TP53;MAPK3
Interaction Between L1 and Ankyrins	7/31	1.259712385287992E-8	3.2061711999749215E-7	0	0	31.886740331491712	580.0133436559852	SCN10A;SCN8A;KCNQ2;KCNQ3;L1CAM;SCN2A;SCN1A
L1CAM Interactions	11/120	1.7998474036211174E-8	4.4377487545533173E-7	0	0	11.233763541180739	200.33146773025274	RPS6KA3;SCN10A;SCN8A;NCAN;TUBB1;KCNQ2;KCNQ3;L1CAM;SCN2A;SCN1A;MAPK3
Synaptic Adhesion-Like Molecules	6/21	3.0730127245449616E-8	7.035205412855202E-7	0	0	43.50989010989011	752.6350502640635	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
Unblocking of NMDA Receptors, Glutamate Binding and Activation	6/21	3.0730127245449616E-8	7.035205412855202E-7	0	0	43.50989010989011	752.6350502640635	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
Inwardly Rectifying K+ Channels	7/35	3.120813554498505E-8	7.035205412855202E-7	0	0	27.325966850828728	472.26340004537775	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ1;KCNJ3
Long-term Potentiation	6/23	5.628070156073091E-8	1.2334853758726859E-6	0	0	38.38720103425986	640.7942509104695	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
MTOR Signalling	7/41	9.948980005458253E-8	2.1215527633260975E-6	0	0	22.49691257718557	362.72246180755553	PRKAA1;PRKAB2;PRKAA2;PRKAG1;PRKAG2;PRKAB1;PRKAG3
TP53 Regulates Metabolic Genes	9/86	1.166503639929349E-7	2.4220299260638326E-6	0	0	12.88652688094029	205.72160684938606	PRKAB2;PRKAA1;PRKAA2;PRKAG1;PRKAG2;MT-CO2;PRKAB1;TP53;PRKAG3
Signaling by Receptor Tyrosine Kinases	20/536	1.7328683402932403E-7	3.505725949977863E-6	0	0	4.451827242524917	69.30746047982394	GABRB3;GABRQ;NTRK1;GABRB2;GABRA1;NTRK2;GABRB1;PDPK1;PLAT;FGF1;MAPK14;FGF2;GABRG3;ESR1;GRIN2B;GABRG2;FGF4;RPS6KA3;PGR;MAPK3
Eicosanoid Ligand-Binding Receptors	5/15	1.9357573960520554E-7	3.81828146371268E-6	0	0	54.10382513661202	836.3151241416274	PTGER4;PTGDR2;PTGER1;PTGER2;PTGER3
CREB1 Phosphorylation Through NMDA Receptor-Mediated Activation of RAS Signaling	6/28	2.019979552317543E-7	3.887228943362296E-6	0	0	29.655344655344656	457.1373828808681	RPS6KA3;PDPK1;GRIN2B;MAPK3;GRIN1;GRIN2D
Regulation of TP53 Activity Through Phosphorylation	9/92	2.0996673481306918E-7	3.944375089702657E-6	0	0	11.95133607053914	183.76752870069652	PRKAB2;PRKAA1;PRKAA2;PRKAG1;PRKAG2;MAPK14;PRKAB1;TP53;PRKAG3
Activation of G Protein Gated Potassium Channels	6/29	2.5271206425764435E-7	4.430884859984032E-6	0	0	28.36454849498328	430.8862839890313	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
G Protein Gated Potassium Channels	6/29	2.5271206425764435E-7	4.430884859984032E-6	0	0	28.36454849498328	430.8862839890313	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
Inhibition of Voltage Gated Ca2+ Channels via Gbeta Gamma Subunits	6/29	2.5271206425764435E-7	4.430884859984032E-6	0	0	28.36454849498328	430.8862839890313	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
IkBA Variant Leads to EDA-ID	4/7	2.588752724168943E-7	4.440273694281078E-6	0	0	143.54347826086956	2177.1123744971987	IKBKB;NFKBIA;NFKB1;NFKB2
G Alpha (I) Signalling Events	15/316	3.27565117134458E-7	5.498912285512497E-6	0	0	5.6202830641599295	83.91970041013808	CHRM2;OPRD1;GABBR2;GABBR1;PTGDR2;CHRM4;HTR1D;PTGER3;HTR1B;CXCR4;OPRM1;POMC;HRH4;PNOC;PDE4A
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation	9/102	5.106955794113695E-7	8.394558586574386E-6	0	0	10.660839790953325	154.4488328826744	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
MyD88 Dependent Cascade Initiated on Endosome	9/103	5.551007480711698E-7	8.938254902615367E-6	0	0	10.546891715202662	151.91865393713064	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor 7 8 (TLR7 8) Cascade	9/107	7.678819181876399E-7	1.2117176669000956E-5	0	0	10.114354121536882	142.40636238491416	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Adrenoceptors	4/9	9.183091086088591E-7	1.4182997461349098E-5	0	0	86.11739130434782	1197.0947584066157	ADRB3;ADRA1D;ADRA1B;ADRA1A
MyD88-independent TLR4 Cascade	9/110	9.706994460238927E-7	1.4182997461349098E-5	0	0	9.812434316057304	135.85559588117232	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
TRIF (TICAM1)-mediated TLR4 Signaling	9/110	9.706994460238927E-7	1.4182997461349098E-5	0	0	9.812434316057304	135.85559588117232	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor 9 (TLR9) Cascade	9/110	9.706994460238927E-7	1.4182997461349098E-5	0	0	9.812434316057304	135.85559588117232	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Negative Regulation of NMDA Receptor-Mediated Neuronal Transmission	5/21	1.2529808650899564E-6	1.7974580046472284E-5	0	0	33.80464480874317	459.40462106826476	GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane	9/115	1.4120529125952129E-6	1.954578505329163E-5	0	0	9.347211974280594	125.91130059039384	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor TLR6 TLR2 Cascade	9/115	1.4120529125952129E-6	1.954578505329163E-5	0	0	9.347211974280594	125.91130059039384	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor 2 (TLR2) Cascade	9/118	1.7524708326499028E-6	2.3435584524758872E-5	0	0	9.08856542463226	120.46424374458662	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor TLR1 TLR2 Cascade	9/118	1.7524708326499028E-6	2.3435584524758872E-5	0	0	9.08856542463226	120.46424374458662	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Selective Autophagy	8/89	1.936448938451749E-6	2.54643035406405E-5	0	0	10.82633744855967	142.41673086964406	PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;PRKAG3;CFTR
Regulation of TP53 Activity	10/160	2.850031232113175E-6	3.6415947967529815E-5	0	0	7.3640449438202245	94.02545582682576	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;MAPK14;PRKAB1;TP53;PRKAG3
Activation of GABAB Receptors	6/43	2.9077372901829893E-6	3.6415947967529815E-5	0	0	17.61954261954262	224.61631399130195	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
GABA B Receptor Activation	6/43	2.9077372901829893E-6	3.6415947967529815E-5	0	0	17.61954261954262	224.61631399130195	GABBR2;KCNJ5;GABBR1;KCNJ6;KCNJ9;KCNJ3
Mitochondrial Biogenesis	8/97	3.7171328737015704E-6	4.582527870860217E-5	0	0	9.849188514357055	123.14004986301393	PRKAB2;PRKAA2;PRKAG1;PRKAG2;PPARA;MAPK14;PRKAB1;PRKAG3
Cardiac Conduction	9/130	3.918065036529848E-6	4.658970822988954E-5	0	0	8.182233713467843	101.86809492585708	KCNH2;CACNB1;SCN10A;KCND2;KCND3;SCN8A;SCN2A;SCN1A;CES1
MyD88 Cascade Initiated on Plasma Membrane	8/98	4.015336070510125E-6	4.658970822988954E-5	0	0	9.73925925925926	121.01408983838434	NFKBIA;IKBKB;RPS6KA3;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor 10 (TLR10) Cascade	8/98	4.015336070510125E-6	4.658970822988954E-5	0	0	9.73925925925926	121.01408983838434	NFKBIA;IKBKB;RPS6KA3;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Toll Like Receptor 5 (TLR5) Cascade	8/98	4.015336070510125E-6	4.658970822988954E-5	0	0	9.73925925925926	121.01408983838434	NFKBIA;IKBKB;RPS6KA3;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Cytokine Signaling in Immune System	22/776	4.091266159697753E-6	4.678273913045692E-5	0	0	3.3498130452845865	41.559978322567595	OPRD1;VCAM1;OPRM1;PTGS2;MAPK14;FGF2;TNF;NFKB1;ICAM1;NFKB2;NFKBIA;IKBKB;POMC;RPS6KA3;CA1;IL1B;ALOX5;TUBB1;BCL2;TP53;CD44;MAPK3
Translocation of SLC2A4 (GLUT4) to the Plasma Membrane	7/71	4.6409261567514405E-6	5.230986768109838E-5	0	0	11.93335635359116	146.54873556865834	PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;PRKAG3
Fatty Acid Metabolism	10/176	6.6697768984972066E-6	7.411907004104642E-5	0	0	6.648842561256261	79.24040131104441	FAAH;PRKAB2;PRKAA2;ALOX5;AKR1C3;PRKAG2;PTGS2;PTGR2;PPARD;PTGS1
Carnitine Shuttle	4/14	7.031517915917162E-6	7.705371716192557E-5	0	0	43.04782608695652	510.7671037794383	PRKAB2;PRKAA2;PRKAG2;PPARD
Toll Like Receptor 3 (TLR3) Cascade	8/106	7.21875594535243E-6	7.802189645045298E-5	0	0	8.940589569160998	105.84610147204475	NFKBIA;IKBKB;RPS6KA3;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Acetylcholine Inhibits Contraction of Outer Hair Cells	3/5	8.061436702747379E-6	8.59523453846984E-5	0	0	160.6216216216216	1883.837641311702	KCNMA1;CHRNA9;CHRNA10
SUMOylation of Intracellular Receptors	5/30	8.192707705149034E-6	8.618728505816783E-5	0	0	21.62513661202186	253.279354526915	PGR;PPARG;NR3C1;PPARA;ESR1
Macroautophagy	9/143	8.542735146658045E-6	8.868707935148945E-5	0	0	7.383557074960393	86.16928102265987	PRKAB2;PRKAA1;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;CFTR;PRKAG3
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	4/15	9.51807062826197E-6	9.752932111297006E-5	0	0	39.13241106719368	452.46139631504474	AKR1C3;PTGS2;PTGR2;PTGS1
Nuclear Receptor Transcription Pathway	6/53	1.0129044924300381E-5	1.024591851958077E-4	0	0	13.863689501987375	159.4338645259186	PGR;PPARG;NR3C1;PPARA;ESR1;PPARD
Toll Like Receptor 4 (TLR4) Cascade	9/148	1.1280062406650047E-5	1.1245310425411466E-4	0	0	7.1161528877456695	81.07058518388135	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
Phase 0 - Rapid Depolarisation	5/32	1.140208915124103E-5	1.1245310425411466E-4	0	0	20.021250758955677	227.87614926933426	CACNB1;SCN10A;SCN8A;SCN2A;SCN1A
Axon Guidance	17/541	1.4794719194995795E-5	1.441115240105146E-4	0	0	3.6593902057943843	40.69695765451136	NCAN;CXCR4;CACNA1D;L1CAM;GRIN2B;GRIN1;CACNB1;RPS6KA3;SCN10A;SCN8A;TUBB1;KCNQ2;KCNQ3;CACNA1S;SCN2A;SCN1A;MAPK3
RIP-mediated NFkB Activation via ZBP1	4/17	1.6353020808154666E-5	1.5734796850773209E-4	0	0	33.108695652173914	364.89417674563794	IKBKB;NFKBIA;NFKB1;NFKB2
Diseases Associated With the TLR Signaling Cascade	5/35	1.7965780234252188E-5	1.6875000720029733E-4	0	0	18.016393442622952	196.8658825670951	IKBKB;NFKBIA;LY96;NFKB1;NFKB2
Diseases of Immune System	5/35	1.7965780234252188E-5	1.6875000720029733E-4	0	0	18.016393442622952	196.8658825670951	IKBKB;NFKBIA;LY96;NFKB1;NFKB2
Arachidonate Metabolism	6/59	1.89728203100325E-5	1.727687194170157E-4	0	0	12.290483101803856	133.628315784051	FAAH;ALOX5;AKR1C3;PTGS2;PTGR2;PTGS1
Autophagy	9/158	1.9050543205678537E-5	1.727687194170157E-4	0	0	6.635184282554085	72.11393599986114	PRKAB2;PRKAA1;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;CFTR;PRKAG3
G Alpha (S) Signalling Events	9/158	1.9050543205678537E-5	1.727687194170157E-4	0	0	6.635184282554085	72.11393599986114	PTGER4;POMC;HTR6;HTR7;ADRB3;HRH2;PTGER2;PDE3A;PDE4A
Nervous System Development	17/567	2.6879991192061403E-5	2.4100355739245963E-4	0	0	3.481701222753854	36.64187061419762	NCAN;CXCR4;CACNA1D;L1CAM;GRIN2B;GRIN1;CACNB1;RPS6KA3;SCN10A;SCN8A;TUBB1;KCNQ2;KCNQ3;CACNA1S;SCN2A;SCN1A;MAPK3
RSK Activation	3/7	2.7825617903728996E-5	2.466787924274402E-4	0	0	80.3027027027027	842.3394925220724	RPS6KA3;PDPK1;MAPK3
ZBP1(DAI) Mediated Induction of Type I IFNs	4/21	3.9930447637638225E-5	3.500569242899618E-4	0	0	25.313299232736572	256.3824966565735	IKBKB;NFKBIA;NFKB1;NFKB2
Toll-like Receptor Cascades	9/174	4.078955058682905E-5	3.536588506923969E-4	0	0	5.986896901980701	60.510073614050775	NFKBIA;IKBKB;RPS6KA3;LY96;MAPK14;TP53;NFKB1;NFKB2;MAPK3
AMPK Inhibits chREBP Transcriptional Activation Activity	3/8	4.4212801851914636E-5	3.7917283327348525E-4	0	0	64.23891891891891	644.0912749010604	PRKAB2;PRKAA2;PRKAG2
Voltage Gated Potassium Channels	5/43	5.012653668138876E-5	4.2526706926468536E-4	0	0	14.217716422203049	140.76904181253028	KCNH2;KCND2;KCND3;KCNQ2;KCNQ3
TAK1-dependent IKK and NF-kappa-B Activation	5/45	6.266231707130963E-5	5.259634911623755E-4	0	0	13.505464480874316	130.7025128591376	IKBKB;NFKBIA;TP53;NFKB1;NFKB2
Interleukin-1 Processing	3/9	6.586026840145816E-5	5.469868607236893E-4	0	0	53.52972972972973	515.3829106051758	IL1B;NFKB1;NFKB2
TRAF6 Mediated NF-kB Activation	4/25	8.195261110482704E-5	6.735480225177972E-4	0	0	20.487577639751553	192.7751859415105	IKBKB;NFKBIA;NFKB1;NFKB2
Developmental Biology	28/1385	1.0065801311403274E-4	8.18754354092493E-4	0	0	2.3799742078113484	21.90476328736582	NCAN;CXCR4;CACNA1D;FGF2;TNF;FGF4;RPS6KA3;TUBB1;CACNA1S;CACNG2;SCN1A;MAPK3;L1CAM;MAPK14;GRIN2B;NFKB1;GRIN1;CACNB1;POMC;SCN10A;SCN8A;KCNQ2;KCNQ3;BCL2;PPARG;SCN2A;PPARA;TP53
Signaling by Activated Point Mutants of FGFR1	3/11	1.275850481113695E-4	0.001027189826121128	0	0	40.14324324324324	359.95351797920557	FGF1;FGF2;FGF4
TRP Channels	4/28	1.297565684594849E-4	0.0010341205304498344	0	0	17.92391304347826	160.41634055895182	TRPA1;TRPV3;TRPM8;TRPV1
Muscle Contraction	9/204	1.3848430372467033E-4	0.0010926411563876488	0	0	5.058100558659218	44.93997699225922	KCNH2;CACNB1;SCN10A;KCND2;KCND3;SCN8A;SCN2A;SCN1A;CES1
Negative Regulation of FGFR3 Signaling	4/29	1.4941704344302253E-4	0.0011672281908568789	0	0	17.206086956521737	151.56444905023295	FGF1;FGF2;FGF4;MAPK3
Insulin Receptor Signalling Cascade	5/54	1.5148713074057734E-4	0.0011717975113168188	0	0	11.01985056317609	96.91969460382806	PDPK1;FGF1;FGF2;FGF4;MAPK3
FGFR3 Mutant Receptor Activation	3/12	1.6893749571931239E-4	0.0012457166740424063	0	0	35.68108108108108	309.925219421179	FGF1;FGF2;FGF4
Hyaluronan Uptake and Degradation	3/12	1.6893749571931239E-4	0.0012457166740424063	0	0	35.68108108108108	309.925219421179	STAB2;HMMR;CD44
Presynaptic Depolarization and Calcium Channel Opening	3/12	1.6893749571931239E-4	0.0012457166740424063	0	0	35.68108108108108	309.925219421179	CACNB1;CACNA1B;CACNG2
Reversible Hydration of Carbon Dioxide	3/12	1.6893749571931239E-4	0.0012457166740424063	0	0	35.68108108108108	309.925219421179	CA1;CA3;CA2
Signaling by Activated Point Mutants of FGFR3	3/12	1.6893749571931239E-4	0.0012457166740424063	0	0	35.68108108108108	309.925219421179	FGF1;FGF2;FGF4
CLEC7A (Dectin-1) Signaling	6/87	1.7108907306814843E-4	0.0012499007282478622	0	0	8.03052503052503	69.6513634838491	IKBKB;NFKBIA;PDPK1;IL1B;NFKB1;NFKB2
Protein-protein Interactions at Synapses	6/88	1.821905673991051E-4	0.0013187922722742561	0	0	7.932189761458054	68.29978159399788	GRIA1;GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
Negative Regulation of FGFR4 Signaling	4/31	1.9506268937597457E-4	0.0013935770119690432	0	0	15.929951690821255	136.07666713751848	FGF1;FGF2;FGF4;MAPK3
Neurexins and Neuroligins	5/57	1.96054560619219E-4	0.0013935770119690432	0	0	10.382513661202186	88.63673976630763	GRIN2A;GRIN2C;GRIN2B;GRIN1;GRIN2D
SUMO E3 Ligases SUMOylate Target Proteins	8/170	2.1043904228560748E-4	0.00147078527360436	0	0	5.390946502057613	45.64144871225887	NFKBIA;PGR;PPARG;NR3C1;PPARA;TP53;ESR1;NFKB2
FGFR2c Ligand Binding and Activation	3/13	2.181012382911408E-4	0.00147078527360436	0	0	32.11135135135135	270.7163918981164	FGF1;FGF2;FGF4
FGFR3 Ligand Binding and Activation	3/13	2.181012382911408E-4	0.00147078527360436	0	0	32.11135135135135	270.7163918981164	FGF1;FGF2;FGF4
FGFR3c Ligand Binding and Activation	3/13	2.181012382911408E-4	0.00147078527360436	0	0	32.11135135135135	270.7163918981164	FGF1;FGF2;FGF4
NF-kB Is Activated and Signals Survival	3/13	2.181012382911408E-4	0.00147078527360436	0	0	32.11135135135135	270.7163918981164	IKBKB;NFKBIA;NFKB1
Phospholipase C-mediated Cascade; FGFR3	3/13	2.181012382911408E-4	0.00147078527360436	0	0	32.11135135135135	270.7163918981164	FGF1;FGF2;FGF4
Negative Regulation of FGFR1 Signaling	4/33	2.4998495430503395E-4	0.0016715095673446763	0	0	14.829835082458771	123.00028085599745	FGF1;FGF2;FGF4;MAPK3
SUMOylation	8/176	2.663482342890187E-4	0.001762154447223584	0	0	5.196825396825397	42.773541735090326	NFKBIA;PGR;PPARG;NR3C1;PPARA;TP53;ESR1;NFKB2
Cellular Responses to Stimuli	20/887	2.697630180285297E-4	0.001762154447223584	0	0	2.601334651507662	21.377681529641396	PRKAA2;HSPA5;PDPK1;GSTP1;LY96;NR3C1;MAPK14;ESR1;NFKB1;NFKBIA;IKBKB;RPS6KA3;TUBB1;ALB;BCL2;MT-CO2;PGR;PPARA;TP53;MAPK3
Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways	5/61	2.7024168328777397E-4	0.001762154447223584	0	0	9.63895394223263	79.19551435181336	IKBKB;BCL2;MAPK14;NFKB1;NFKB2
FGFR1c Ligand Binding and Activation	3/14	2.7566614068201377E-4	0.0017682974390090152	0	0	29.190663390663392	239.2560199035724	FGF1;FGF2;FGF4
FGFR4 Ligand Binding and Activation	3/14	2.7566614068201377E-4	0.0017682974390090152	0	0	29.190663390663392	239.2560199035724	FGF1;FGF2;FGF4
Negative Regulation of FGFR2 Signaling	4/34	2.8124755599731306E-4	0.001789550981305484	0	0	14.334782608695653	117.20512889222003	FGF1;FGF2;FGF4;MAPK3
Metabolism of Lipids	18/758	2.9845750379282486E-4	0.0018838637639403107	0	0	2.7289030206677265	22.15018654016229	FAAH;PRKAB2;PRKAA2;PLA2G2E;AKR1C1;PLA2G2A;AKR1C3;AKR1B1;PRKAG2;PTGS2;PTGR2;PTGS1;POMC;ALOX5;ALB;PPARG;PPARA;PPARD
MAP Kinase Activation	5/63	3.144872027350045E-4	0.0019537827004560515	0	0	9.305634068211797	75.04591103490282	IKBKB;RPS6KA3;MAPK14;NFKB1;MAPK3
NCAM Signaling for Neurite Out-Growth	5/63	3.144872027350045E-4	0.0019537827004560515	0	0	9.305634068211797	75.04591103490282	CACNB1;NCAN;CACNA1D;CACNA1S;MAPK3
Phospholipase C-mediated Cascade; FGFR4	3/15	3.4220363603582103E-4	0.002109364600252053	0	0	26.756756756756758	213.52171690220925	FGF1;FGF2;FGF4
Interleukin-1 Family Signaling	7/140	3.6387597142197405E-4	0.002225566987999516	0	0	5.722302995056703	45.313186342479646	NFKBIA;IKBKB;IL1B;ALOX5;TP53;NFKB1;NFKB2
Interleukin-1 Signaling	6/102	4.0620239251886657E-4	0.002465336059210659	0	0	6.770604395604396	52.86934107668799	NFKBIA;IKBKB;IL1B;TP53;NFKB1;NFKB2
p75NTR Signals via NF-kB	3/16	4.182670779051345E-4	0.0025000963974784176	0	0	24.697297297297297	192.12991718242694	IKBKB;NFKBIA;NFKB1
Phospholipase C-mediated Cascade FGFR1	3/16	4.182670779051345E-4	0.0025000963974784176	0	0	24.697297297297297	192.12991718242694	FGF1;FGF2;FGF4
Activated Point Mutants of FGFR2	3/17	5.043920864894578E-4	0.002969890718210315	0	0	22.932046332046333	174.1036878963936	FGF1;FGF2;FGF4
Hyaluronan Metabolism	3/17	5.043920864894578E-4	0.002969890718210315	0	0	22.932046332046333	174.1036878963936	STAB2;HMMR;CD44
Signaling by FGFR3	4/40	5.304157410164595E-4	0.0030999853308295295	0	0	11.942028985507246	90.06498463950325	FGF1;FGF2;FGF4;MAPK3
Drug ADME	6/109	5.787041003079901E-4	0.0033165415825819225	0	0	6.3082257548276965	47.02605205637702	GSTP1;AKR1C1;ALB;SLC29A1;CES1;SLC29A2
Signaling by FGFR4	4/41	5.834747833805312E-4	0.0033165415825819225	0	0	11.618683901292597	86.51863799562007	FGF1;FGF2;FGF4;MAPK3
Interleukin-17 Signaling	5/72	5.848075609172472E-4	0.0033165415825819225	0	0	8.051953348014028	59.940574317839065	IKBKB;RPS6KA3;MAPK14;NFKB1;MAPK3
FGFR1 Ligand Binding and Activation	3/18	6.010968901257477E-4	0.0033165415825819225	0	0	21.402162162162163	158.73458084740201	FGF1;FGF2;FGF4
MECP2 Regulates Neuronal Receptors and Channels	3/18	6.010968901257477E-4	0.0033165415825819225	0	0	21.402162162162163	158.73458084740201	GRIN2A;OPRM1;GRIN2B
PI-3K Cascade FGFR3	3/18	6.010968901257477E-4	0.0033165415825819225	0	0	21.402162162162163	158.73458084740201	FGF1;FGF2;FGF4
Phospholipase C-mediated Cascade; FGFR2	3/18	6.010968901257477E-4	0.0033165415825819225	0	0	21.402162162162163	158.73458084740201	FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR3	3/18	6.010968901257477E-4	0.0033165415825819225	0	0	21.402162162162163	158.73458084740201	FGF1;FGF2;FGF4
PI3K AKT Signaling in Cancer	6/110	6.073816497976762E-4	0.0033279452895164344	0	0	6.247252747252747	46.26936048125509	NTRK2;PDPK1;FGF1;FGF2;ESR1;FGF4
PI5P, PP2A and IER3 Regulate PI3K AKT Signaling	6/111	6.371499009660973E-4	0.003459683757821473	0	0	6.187441130298273	45.53032024866506	NTRK2;FGF1;FGF2;ESR1;FGF4;MAPK3
NCAM1 Interactions	4/42	6.401949665930736E-4	0.003459683757821473	0	0	11.312356979405035	83.18810704397336	CACNB1;NCAN;CACNA1D;CACNA1S
Transcriptional Regulation by TP53	11/362	6.549886544149045E-4	0.0035155513492065283	0	0	3.445699937225361	25.260056323178098	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;MT-CO2;MAPK14;PRKAB1;TP53;PRKAG3
PI3K Cascade	4/44	7.651744937953645E-4	0.00407920726759826	0	0	10.745652173913044	77.10442410686157	PDPK1;FGF1;FGF2;FGF4
FGFR2 Ligand Binding and Activation	3/20	8.282338460568783E-4	0.00427108826495998	0	0	18.88235294117647	133.9932365669352	FGF1;FGF2;FGF4
FRS-mediated FGFR3 Signaling	3/20	8.282338460568783E-4	0.00427108826495998	0	0	18.88235294117647	133.9932365669352	FGF1;FGF2;FGF4
PI-3K Cascade FGFR4	3/20	8.282338460568783E-4	0.00427108826495998	0	0	18.88235294117647	133.9932365669352	FGF1;FGF2;FGF4
Ras Activation Upon Ca2+ Influx Through NMDA Receptor	3/20	8.282338460568783E-4	0.00427108826495998	0	0	18.88235294117647	133.9932365669352	GRIN2B;GRIN1;GRIN2D
SHC-mediated Cascade FGFR4	3/20	8.282338460568783E-4	0.00427108826495998	0	0	18.88235294117647	133.9932365669352	FGF1;FGF2;FGF4
NGF-independant TRKA Activation	2/5	8.626862493694165E-4	0.004419866563327725	0	0	71.0	500.9376238661725	NTRK1;NTRK2
Negative Regulation of the PI3K AKT Network	6/118	8.784790177702225E-4	0.004471741580778745	0	0	5.798665620094192	40.807057045262496	NTRK2;FGF1;FGF2;ESR1;FGF4;MAPK3
Interleukin-10 Signaling	4/46	9.064692365533934E-4	0.0045846424848758165	0	0	10.232919254658386	71.69135610776095	IL1B;PTGS2;TNF;ICAM1
PI-3K Cascade FGFR1	3/21	9.596184918716641E-4	0.004792018924599639	0	0	17.832432432432434	123.91712282511412	FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR1	3/21	9.596184918716641E-4	0.004792018924599639	0	0	17.832432432432434	123.91712282511412	FGF1;FGF2;FGF4
Signaling by Insulin Receptor	5/82	0.0010575073918442585	0.005247631019906414	0	0	7.0026967567951175	47.981362347863566	PDPK1;FGF1;FGF2;FGF4;MAPK3
IRS-mediated Signalling	4/48	0.0010651974767198027	0.005252755057074527	0	0	9.766798418972332	66.84978033611127	PDPK1;FGF1;FGF2;FGF4
ERK MAPK Targets	3/22	0.0011034885654210486	0.005341426246117837	0	0	16.89302987197724	115.02934839149952	RPS6KA3;MAPK14;MAPK3
FRS-mediated FGFR4 Signaling	3/22	0.0011034885654210486	0.005341426246117837	0	0	16.89302987197724	115.02934839149952	FGF1;FGF2;FGF4
Signaling by FGFR3 in Disease	3/22	0.0011034885654210486	0.005341426246117837	0	0	16.89302987197724	115.02934839149952	FGF1;FGF2;FGF4
Constitutive Signaling by Aberrant PI3K in Cancer	5/83	0.001116840986173152	0.005373094744454981	0	0	6.912568306010929	46.98646270833117	NTRK2;FGF1;FGF2;ESR1;FGF4
Cellular Responses to Stress	17/787	0.0012538406860712475	0.005899273792527631	0	0	2.458525100630364	16.426743363157907	PRKAA2;HSPA5;GSTP1;LY96;NR3C1;MAPK14;ESR1;NFKB1;RPS6KA3;TUBB1;ALB;BCL2;MT-CO2;PGR;PPARA;TP53;MAPK3
FRS-mediated FGFR1 Signaling	3/23	0.0012602802696559034	0.005899273792527631	0	0	16.04756756756757	107.14031945830344	FGF1;FGF2;FGF4
PI-3K Cascade FGFR2	3/23	0.0012602802696559034	0.005899273792527631	0	0	16.04756756756757	107.14031945830344	FGF1;FGF2;FGF4
SHC-mediated Cascade FGFR2	3/23	0.0012602802696559034	0.005899273792527631	0	0	16.04756756756757	107.14031945830344	FGF1;FGF2;FGF4
Generic Transcription Pathway	23/1230	0.001270834287060715	0.005899273792527631	0	0	2.1486530591750146	14.327394090339713	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;OPRM1;NR3C1;MAPK14;PRKAB1;ESR1;GRIN2B;NFKB1;PRKAG3;POMC;GRIN2A;MT-CO2;PGR;PPARG;PPARA;TP53;PPARD;MAPK3
Activation of TRKA Receptors	2/6	0.001286026732971803	0.005899273792527631	0	0	53.24731182795699	354.42464334302275	NTRK1;NTRK2
Biosynthesis of EPA-derived SPMs	2/6	0.001286026732971803	0.005899273792527631	0	0	53.24731182795699	354.42464334302275	ALOX5;PTGS2
CLEC7A Inflammasome Pathway	2/6	0.001286026732971803	0.005899273792527631	0	0	53.24731182795699	354.42464334302275	IL1B;NFKB1
PIP3 Activates AKT Signaling	9/281	0.0014038644954572756	0.006402595878125957	0	0	3.6119783108774235	23.725375220794533	NTRK2;PDPK1;PPARG;FGF1;FGF2;TP53;ESR1;FGF4;MAPK3
IRS-related Events Triggered by IGF1R	4/52	0.0014394271356200164	0.006489760057166817	0	0	8.951086956521738	58.57152761088496	PDPK1;FGF1;FGF2;FGF4
Signaling by FGFR1	4/52	0.0014394271356200164	0.006489760057166817	0	0	8.951086956521738	58.57152761088496	FGF1;FGF2;FGF4;MAPK3
C-type Lectin Receptors (CLRs)	6/131	0.001507333552088388	0.006757307798850786	0	0	5.192175824175824	33.73571095097483	NFKBIA;IKBKB;PDPK1;IL1B;NFKB1;NFKB2
IGF1R Signaling Cascade	4/53	0.0015456251296505923	0.006889820493188233	0	0	8.767968056787932	56.74915494944085	PDPK1;FGF1;FGF2;FGF4
Downstream Signaling of Activated FGFR3	3/25	0.0016142964171781654	0.007075999295297625	0	0	14.587223587223587	93.77916093571022	FGF1;FGF2;FGF4
FRS-mediated FGFR2 Signaling	3/25	0.0016142964171781654	0.007075999295297625	0	0	14.587223587223587	93.77916093571022	FGF1;FGF2;FGF4
Inflammasomes	3/25	0.0016142964171781654	0.007075999295297625	0	0	14.587223587223587	93.77916093571022	BCL2;NFKB1;NFKB2
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	4/54	0.0016571566484326213	0.007223738097311261	0	0	8.592173913043478	55.012699554251626	PDPK1;FGF1;FGF2;FGF4
Signaling by NTRKs	6/134	0.0016917219082425636	0.007333893327491113	0	0	5.069711538461538	32.35494156389549	NTRK1;RPS6KA3;NTRK2;MAPK14;GRIN2B;MAPK3
Intrinsic Pathway for Apoptosis	4/55	0.0017741594955385204	0.007549550090208748	0	0	8.423273657289002	53.35662464931995	C1QBP;BCL2;TP53;MAPK3
Activated NTRK2 Signals Through FYN	2/7	0.0017893103509113253	0.007549550090208748	0	0	42.59569892473118	269.4571972396255	NTRK2;GRIN2B
DEx H-box Helicases Activate Type I IFN and Inflammatory Cytokines Production	2/7	0.0017893103509113253	0.007549550090208748	0	0	42.59569892473118	269.4571972396255	NFKB1;NFKB2
Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors	2/7	0.0017893103509113253	0.007549550090208748	0	0	42.59569892473118	269.4571972396255	CHRNA3;CHRNB4
Phase 1 - Inactivation of Fast Na+ Channels	2/7	0.0017893103509113253	0.007549550090208748	0	0	42.59569892473118	269.4571972396255	KCND2;KCND3
Cell Recruitment (Pro-Inflammatory Response)	3/27	0.0020248529427620335	0.00840846827283813	0	0	13.37027027027027	82.92586844565636	IL1B;NFKB1;NFKB2
Downstream Signaling of Activated FGFR4	3/27	0.0020248529427620335	0.00840846827283813	0	0	13.37027027027027	82.92586844565636	FGF1;FGF2;FGF4
Purinergic Signaling in Leishmaniasis Infection	3/27	0.0020248529427620335	0.00840846827283813	0	0	13.37027027027027	82.92586844565636	IL1B;NFKB1;NFKB2
Organelle Biogenesis and Maintenance	9/297	0.002048728008735026	0.008463070151266678	0	0	3.4085195530726256	21.100563552027772	PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PPARA;MAPK14;PRKAB1;PRKAG3
Defective CHST14 Causes EDS, Musculocontractural Type	2/8	0.002371012885390744	0.009544536564149475	0	0	35.494623655913976	214.5450533466253	VCAN;NCAN
Defective CHST3 Causes SEDCJD	2/8	0.002371012885390744	0.009544536564149475	0	0	35.494623655913976	214.5450533466253	VCAN;NCAN
Defective CHSY1 Causes TPBS	2/8	0.002371012885390744	0.009544536564149475	0	0	35.494623655913976	214.5450533466253	VCAN;NCAN
Erythrocytes Take up Oxygen and Release Carbon Dioxide	2/8	0.002371012885390744	0.009544536564149475	0	0	35.494623655913976	214.5450533466253	CA1;CA2
FGFR1b Ligand Binding and Activation	2/8	0.002371012885390744	0.009544536564149475	0	0	35.494623655913976	214.5450533466253	FGF1;FGF2
Innate Immune System	21/1149	0.002724081598347157	0.010905698972916924	0	0	2.0828767995923045	12.300687083001389	CHRNB4;TNFAIP6;PDPK1;GSTP1;PLA2G2A;LY96;MAPK14;ORM2;NFKB1;NFKB2;NFKBIA;IKBKB;RPS6KA3;PGRMC1;IL1B;ALOX5;BCL2;TP53;CD44;LTF;MAPK3
Peptide Ligand-Binding Receptors	7/198	0.002736791377233905	0.010905698972916924	0	0	3.972896358219317	23.443938547954396	OPRD1;POMC;EDNRA;PNOC;TACR3;CXCR4;OPRM1
Downstream Signaling of Activated FGFR2	3/30	0.0027530995421551083	0.010915555471157691	0	0	11.882882882882884	70.04992607679566	FGF1;FGF2;FGF4
Hemostasis	15/707	0.0028601526485431492	0.011283302198502723	0	0	2.3956697517457983	14.031150931083689	HSPA5;PDPK1;PLAT;L1CAM;MAPK14;ORM2;THBD;C1QBP;TUBB1;ALB;KCNMA1;HABP4;TP53;CD44;MAPK3
Transcriptional Regulation by MECP2	4/63	0.0029234607295344417	0.01147567420697848	0	0	7.278187177597641	42.468128897685276	GRIN2A;PPARG;OPRM1;GRIN2B
Downstream Signaling of Activated FGFR1	3/31	0.0030271760701243455	0.011650936191844432	0	0	11.457915057915057	66.45734053880396	FGF1;FGF2;FGF4
FGFR1 Mutant Receptor Activation	3/31	0.0030271760701243455	0.011650936191844432	0	0	11.457915057915057	66.45734053880396	FGF1;FGF2;FGF4
MAPK Targets Nuclear Events Mediated by MAP Kinases	3/31	0.0030271760701243455	0.011650936191844432	0	0	11.457915057915057	66.45734053880396	RPS6KA3;MAPK14;MAPK3
Turbulent Flow Shear Stress Activates Signaling by PIEZO1 and Integrins in Endothelial Cells	3/31	0.0030271760701243455	0.011650936191844432	0	0	11.457915057915057	66.45734053880396	IKBKB;NFKBIA;NFKB1
Cellular Response to Chemical Stress	7/202	0.003058005767674625	0.011712458983957666	0	0	3.89060773480663	22.526588769983046	PRKAA2;GSTP1;ALB;BCL2;MT-CO2;PPARA;NFKB1
Cytosolic Sensors of Pathogen-Associated DNA	4/64	0.003095787710304391	0.011799886490000794	0	0	7.156521739130435	41.348327932864876	IKBKB;NFKBIA;NFKB1;NFKB2
Stimuli-sensing Channels	5/107	0.0034138474332184	0.012949642426967873	0	0	5.279652844744455	29.987981204805045	TRPA1;TRPV3;TRPM8;TRPV1;ASIC3
Intracellular Signaling by Second Messengers	9/321	0.003438273515452789	0.012979893797570575	0	0	3.142458100558659	17.826491748475803	NTRK2;PDPK1;PPARG;FGF1;FGF2;TP53;ESR1;FGF4;MAPK3
Metabolism of Steroids	6/155	0.0035026915635454083	0.013160112588749176	0	0	4.35054207537429	24.59893762261914	POMC;AKR1C1;ALB;AKR1C3;AKR1B1;PPARA
Integration of Energy Metabolism	5/108	0.0035528167063279795	0.013285177162525004	0	0	5.228128813199639	29.486722584599708	CHRM3;PRKAB2;PRKAA2;PRKAG2;CACNA1D
FGFR2 Mutant Receptor Activation	3/33	0.003624187043741101	0.013488130082602495	0	0	10.692972972972973	60.0958477197196	FGF1;FGF2;FGF4
Activation of the AP-1 Family of Transcription Factors	2/10	0.0037636841126858765	0.013747901689394243	0	0	26.618279569892472	148.59273886129486	MAPK14;MAPK3
FGFR2b Ligand Binding and Activation	2/10	0.0037636841126858765	0.013747901689394243	0	0	26.618279569892472	148.59273886129486	FGF1;FGF2
Neurotransmitter Clearance	2/10	0.0037636841126858765	0.013747901689394243	0	0	26.618279569892472	148.59273886129486	SLC6A3;SLC6A4
Prednisone ADME	2/10	0.0037636841126858765	0.013747901689394243	0	0	26.618279569892472	148.59273886129486	AKR1C1;ALB
Signalling to ERKs	3/34	0.003947698572665306	0.014345614452958776	0	0	10.347515257192677	57.2695908619354	NTRK1;MAPK14;MAPK3
Metabolism	33/2181	0.003963680545937913	0.014345614452958776	0	0	1.75080194629663	9.682954175466497	CHRM3;FAAH;PRKAA2;GLO1;NCAN;GSTP1;STAB2;AKR1B1;PRKAG2;CACNA1D;HMMR;PTGS2;PTGS1;CA1;CA3;CA2;ALOX5;PRKAB2;PLA2G2E;AKR1C1;PLA2G2A;AKR1C3;PTGR2;POMC;VCAN;AKR1B10;ALB;MT-CO2;PPARG;PPARA;CD44;CES1;PPARD
RNA Polymerase II Transcription	23/1360	0.004503394125658777	0.01622455691846929	0	0	1.9261802769656173	10.407005485644552	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;OPRM1;NR3C1;MAPK14;PRKAB1;ESR1;GRIN2B;NFKB1;PRKAG3;POMC;GRIN2A;MT-CO2;PGR;PPARG;PPARA;TP53;PPARD;MAPK3
Dermatan Sulfate Biosynthesis	2/11	0.004571709884427514	0.016395814085515038	0	0	23.659498207885303	127.47425305165838	VCAN;NCAN
Signaling by NTRK1 (TRKA)	5/115	0.004641672829785881	0.016571402093669956	0	0	4.893691008445106	26.2922380292639	NTRK1;RPS6KA3;NTRK2;MAPK14;MAPK3
Signaling by FGFR1 in Disease	3/38	0.005414610331102713	0.018839969947749193	0	0	9.163088803088803	47.81899335285782	FGF1;FGF2;FGF4
Erythrocytes Take up Carbon Dioxide and Release Oxygen	2/12	0.005452268217812193	0.018839969947749193	0	0	21.29247311827957	110.97048401698518	CA1;CA2
Frs2-mediated Activation	2/12	0.005452268217812193	0.018839969947749193	0	0	21.29247311827957	110.97048401698518	NTRK1;MAPK3
O2 CO2 Exchange in Erythrocytes	2/12	0.005452268217812193	0.018839969947749193	0	0	21.29247311827957	110.97048401698518	CA1;CA2
SUMOylation of Immune Response Proteins	2/12	0.005452268217812193	0.018839969947749193	0	0	21.29247311827957	110.97048401698518	NFKBIA;NFKB2
Transport of Nucleosides and Free Purine and Pyrimidine Bases Across the Plasma Membrane	2/12	0.005452268217812193	0.018839969947749193	0	0	21.29247311827957	110.97048401698518	SLC29A1;SLC29A2
Extra-nuclear Estrogen Signaling	4/75	0.005468128159739626	0.018839969947749193	0	0	6.044396815676668	31.484168507126057	PDPK1;BCL2;ESR1;MAPK3
Signaling by FGFR2	4/75	0.005468128159739626	0.018839969947749193	0	0	6.044396815676668	31.484168507126057	FGF1;FGF2;FGF4;MAPK3
Immune System	32/2150	0.005829034006549672	0.019996121005076917	0	0	1.7136631074308128	8.8166321519237	OPRD1;TNFAIP6;GSTP1;LY96;PTGS2;FGF2;TNF;ORM2;ICAM1;IKBKB;RPS6KA3;CA1;PGRMC1;ALOX5;TUBB1;MAPK3;CHRNB4;VCAM1;HSPA5;PDPK1;PLA2G2A;OPRM1;MAPK14;NFKB1;NFKB2;NFKBIA;POMC;IL1B;BCL2;TP53;CD44;LTF
Sensory Processing of Sound	4/77	0.006000707437655362	0.020495922806537146	0	0	5.878201310303752	30.07216023643534	KCNMA1;CHRNA9;CHRNA10;CACNA1D
FGFRL1 Modulation of FGFR1 Signaling	2/13	0.006403938881279388	0.021685441104418182	0	0	19.35581622678397	97.763170079228	FGF2;FGF4
Synthesis of Bile Acids and Bile Salts via 24-Hydroxycholesterol	2/13	0.006403938881279388	0.021685441104418182	0	0	19.35581622678397	97.763170079228	AKR1C1;AKR1C3
Glycosaminoglycan Metabolism	5/127	0.007028927601856791	0.023700102042158153	0	0	4.409656902266416	21.861849203777595	VCAN;NCAN;STAB2;HMMR;CD44
CS DS Degradation	2/14	0.007425321680758053	0.024719741797966682	0	0	17.741935483870968	86.98621287655507	VCAN;NCAN
Prolonged ERK Activation Events	2/14	0.007425321680758053	0.024719741797966682	0	0	17.741935483870968	86.98621287655507	NTRK1;MAPK3
Synthesis of Bile Acids and Bile Salts via 27-Hydroxycholesterol	2/14	0.007425321680758053	0.024719741797966682	0	0	17.741935483870968	86.98621287655507	AKR1C1;AKR1C3
Signaling by FGFR2 in Disease	3/43	0.007654372956756307	0.025375211188574484	0	0	8.015675675675675	39.05620471648322	FGF1;FGF2;FGF4
Transcriptional Regulation of White Adipocyte Differentiation	4/84	0.00813382052089498	0.02670965421849171	0	0	5.36195652173913	25.800257762166975	PPARG;PPARA;TNF;NFKB1
Bile Acid and Bile Salt Metabolism	3/44	0.008158462188411283	0.02670965421849171	0	0	7.81977587343441	37.60295299791638	AKR1C1;ALB;AKR1C3
Retinoid Metabolism and Transport	3/44	0.008158462188411283	0.02670965421849171	0	0	7.81977587343441	37.60295299791638	AKR1B10;AKR1C1;AKR1C3
Transport of Small Molecules	14/724	0.008649151385650375	0.028199092740818787	0	0	2.1647077869515945	10.282998560513551	SLC15A1;TRPA1;TRPV3;TRPV1;SLC6A2;SLC6A3;CA1;CA2;ALB;TRPM8;SLC29A1;ASIC3;CFTR;SLC29A2
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta	4/86	0.008823601415696882	0.0286494712633121	0	0	5.230646871686108	24.742660544828183	IKBKB;NFKBIA;NFKB1;NFKB2
MAP3K8 (TPL2)-dependent MAPK1 3 Activation	2/16	0.009671721638467879	0.03127454251127523	0	0	15.20583717357911	70.53301999798445	IKBKB;NFKB1
Metabolism of Fat-Soluble Vitamins	3/48	0.010367359678155212	0.033251409699449036	0	0	7.123243243243243	32.5467601327802	AKR1B10;AKR1C1;AKR1C3
Recycling Pathway of L1	3/48	0.010367359678155212	0.033251409699449036	0	0	7.123243243243243	32.5467601327802	RPS6KA3;TUBB1;L1CAM
Downstream TCR Signaling	4/91	0.010712168445254883	0.03408024557784719	0	0	4.928785607196402	22.358819541730686	IKBKB;NFKBIA;PDPK1;NFKB1
Signaling by FGFR	4/91	0.010712168445254883	0.03408024557784719	0	0	4.928785607196402	22.358819541730686	FGF1;FGF2;FGF4;MAPK3
Acyl Chain Remodelling of PI	2/17	0.010894036396237058	0.034244600464665494	0	0	14.191397849462366	64.13858681760826	PLA2G2E;PLA2G2A
Biosynthesis of DHA-derived SPMs	2/17	0.010894036396237058	0.034244600464665494	0	0	14.191397849462366	64.13858681760826	ALOX5;PTGS2
The NLRP3 Inflammasome	2/17	0.010894036396237058	0.034244600464665494	0	0	14.191397849462366	64.13858681760826	NFKB1;NFKB2
Cellular Responses to Mechanical Stimuli	4/93	0.011535129913119063	0.03597319170533969	0	0	4.817537860283341	21.497579212868487	IKBKB;NFKBIA;PDPK1;NFKB1
Response of Endothelial Cells to Shear Stress	4/93	0.011535129913119063	0.03597319170533969	0	0	4.817537860283341	21.497579212868487	IKBKB;NFKBIA;PDPK1;NFKB1
Platelet Activation, Signaling and Aggregation	7/262	0.012145813985498681	0.037395094057036705	0	0	2.966070848228794	13.0826583811148	HSPA5;PDPK1;ALB;HABP4;MAPK14;ORM2;MAPK3
Acyl Chain Remodelling of PG	2/18	0.012180658013508787	0.037395094057036705	0	0	13.303763440860216	58.641738614551095	PLA2G2E;PLA2G2A
Gastrin-CREB Signalling Pathway via PKC and MAPK	2/18	0.012180658013508787	0.037395094057036705	0	0	13.303763440860216	58.641738614551095	RPS6KA3;MAPK3
Regulation of NF-kappa B Signaling	2/18	0.012180658013508787	0.037395094057036705	0	0	13.303763440860216	58.641738614551095	IKBKB;TP53
Programmed Cell Death	6/202	0.012264560124117316	0.03750673619352156	0	0	3.2993944830679522	14.520771933447902	C1QBP;IL1B;BCL2;LY96;TP53;MAPK3
RAF MAP Kinase Cascade	7/265	0.012863966088205213	0.039187912137428234	0	0	2.931131954259283	12.76017060899561	FGF1;FGF2;GRIN2B;FGF4;GRIN2D;MAPK3;GRIN1
Biosynthesis of Specialized Proresolving Mediators (SPMs)	2/19	0.013530282842620044	0.040745775430638224	0	0	12.520556609740671	53.87376314501273	ALOX5;PTGS2
Na+ Cl- Dependent Neurotransmitter Transporters	2/19	0.013530282842620044	0.040745775430638224	0	0	12.520556609740671	53.87376314501273	SLC6A2;SLC6A3
Signaling by FGFR2 IIIa TM	2/19	0.013530282842620044	0.040745775430638224	0	0	12.520556609740671	53.87376314501273	FGF1;FGF2
Signaling by Nuclear Receptors	7/270	0.014128104846478404	0.04238431453943521	0	0	2.8746717643845976	12.244920841261555	PDPK1;BCL2;AKR1C3;PGR;ESR1;PPARD;MAPK3
Interferon Gamma Signaling	4/99	0.01424418760161315	0.04249299559947621	0	0	4.511899313501144	19.18191736076766	VCAM1;CD44;ICAM1;MAPK3
Activation of NF-kappaB in B Cells	3/54	0.0142720454168076	0.04249299559947621	0	0	6.283306836248013	26.70061407499588	IKBKB;NFKBIA;NFKB1
MAPK1 MAPK3 Signaling	7/271	0.014391232412425138	0.04268677583986253	0	0	2.8636363636363638	12.145071610862905	FGF1;FGF2;GRIN2B;FGF4;GRIN2D;MAPK3;GRIN1
Apoptotic Factor-Mediated Response	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	C1QBP;MAPK3
Chondroitin Sulfate Biosynthesis	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	VCAN;NCAN
Defective B3GALT6 Causes EDSP2 and SEMDJL1	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	VCAN;NCAN
Defective B3GAT3 Causes JDSSDHD	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	VCAN;NCAN
Defective B4GALT7 Causes EDS, Progeroid Type	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	VCAN;NCAN
Signalling to RAS	2/20	0.014941625829534715	0.04333164599397714	0	0	11.824372759856631	49.70498395663007	NTRK1;MAPK14
Sensory Processing of Sound by Outer Hair Cells of the Cochlea	3/55	0.014993079032136576	0.04333164599397714	0	0	6.162162162162162	25.88210758769852	KCNMA1;CHRNA9;CHRNA10
Neutrophil Degranulation	10/478	0.015241535306260816	0.043888946557079506	0	0	2.3220973782771535	9.715030767747638	CHRNB4;PGRMC1;TNFAIP6;GSTP1;ALOX5;MAPK14;ORM2;NFKB1;CD44;LTF
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand	3/56	0.01573438124157551	0.04514337018037482	0	0	6.0455889852116265	25.10072366778396	TUBB1;PGR;NR3C1
Signal Transduction by L1	2/21	0.01641342029144577	0.0469209732244591	0	0	11.201471420486701	46.03419387729711	L1CAM;MAPK3
Interferon Signaling	7/280	0.016919197052371434	0.04819222553906521	0	0	2.7679558011049723	11.291339763057016	IKBKB;VCAM1;TUBB1;TP53;CD44;ICAM1;MAPK3
Acyl Chain Remodelling of PS	2/22	0.017944417677846457	0.05092858110726926	0	0	10.640860215053763	42.78132529848109	PLA2G2E;PLA2G2A
Cytoprotection by HMOX1	3/59	0.018080424287632454	0.05113066223276705	0	0	5.7208494208494205	22.95734227691729	ALB;MT-CO2;PPARA
Azathioprine ADME	2/23	0.019533387354205938	0.05465192419315066	0	0	10.133640552995391	39.8822608386582	SLC29A1;SLC29A2
IKK Complex Recruitment Mediated by RIP1	2/23	0.019533387354205938	0.05465192419315066	0	0	10.133640552995391	39.8822608386582	IKBKB;LY96
Synthesis of Bile Acids and Bile Salts via 7Alpha-Hydroxycholesterol	2/23	0.019533387354205938	0.05465192419315066	0	0	10.133640552995391	39.8822608386582	AKR1C1;AKR1C3
Nuclear Events (Kinase and Transcription Factor Activation)	3/61	0.019746631567424136	0.05485947995316071	0	0	5.523019571295434	21.676594533570892	RPS6KA3;MAPK14;MAPK3
Regulation of PTEN Gene Transcription	3/61	0.019746631567424136	0.05485947995316071	0	0	5.523019571295434	21.676594533570892	PPARG;TP53;MAPK3
Adipogenesis	4/110	0.020188821814023206	0.05589115933776951	0	0	4.041427399507794	15.772180468001716	PPARG;PPARA;TNF;NFKB1
Cellular Senescence	5/167	0.02092694019481424	0.05773201333464488	0	0	3.3141064561829587	12.814714907512634	RPS6KA3;MAPK14;TP53;NFKB1;MAPK3
Estrogen-dependent Nuclear Events Downstream of ESR-membrane Signaling	2/24	0.02117911636673255	0.057821186205370176	0	0	9.672531769305962	37.285091822325455	BCL2;MAPK3
G-protein Activation	2/24	0.02117911636673255	0.057821186205370176	0	0	9.672531769305962	37.285091822325455	POMC;OPRM1
RHO GTPases Activate NADPH Oxidases	2/24	0.02117911636673255	0.057821186205370176	0	0	9.672531769305962	37.285091822325455	MAPK14;MAPK3
Apoptosis	5/168	0.02140996619419499	0.0582498735421374	0	0	3.2936068926212747	12.660291435173818	C1QBP;BCL2;LY96;TP53;MAPK3
Signaling by FGFR in Disease	3/63	0.02149482405853181	0.05827978069478213	0	0	5.338378378378378	20.499069295555547	FGF1;FGF2;FGF4
TCR Signaling	4/113	0.022038285132398323	0.0595486540050078	0	0	3.929597128041484	14.991311285713868	NFKBIA;IKBKB;PDPK1;NFKB1
Defective Intrinsic Pathway for Apoptosis	2/25	0.02288040923774288	0.06140354724006507	0	0	9.251519401589528	34.94737609422492	C1QBP;TP53
Signaling by NTRK2 (TRKB)	2/25	0.02288040923774288	0.06140354724006507	0	0	9.251519401589528	34.94737609422492	NTRK2;GRIN2B
Extracellular Matrix Organization	7/300	0.023632210093673188	0.063206148352231	0	0	2.576376972828239	9.648904469696955	VCAN;VCAM1;NCAN;FGF2;HAPLN1;CD44;ICAM1
A Tetrasaccharide Linker Sequence Is Required for GAG Synthesis	2/26	0.024636087730328125	0.065668490605503	0	0	8.865591397849462	32.83409834267396	VCAN;NCAN
Downstream Signaling Events of B Cell Receptor (BCR)	3/68	0.026224329323324153	0.06966665264681063	0	0	4.926486486486486	17.937670815361024	IKBKB;NFKBIA;NFKB1
Acyl Chain Remodelling of PC	2/27	0.026444990645774706	0.06978293518232857	0	0	8.510537634408601	30.91613243322865	PLA2G2E;PLA2G2A
Pyroptosis	2/27	0.026444990645774706	0.06978293518232857	0	0	8.510537634408601	30.91613243322865	IL1B;TP53
MAPK Family Signaling Cascades	7/314	0.02930154537448233	0.07706306433488852	0	0	2.457123832490507	8.67392975000751	FGF1;FGF2;GRIN2B;FGF4;GRIN2D;MAPK3;GRIN1
Gene Expression (Transcription)	23/1615	0.02984270802707524	0.07822557021050619	0	0	1.5953251104004873	5.60248626361955	PRKAB2;PRKAA1;PRKAA2;PDPK1;PRKAG1;PRKAG2;OPRM1;NR3C1;MAPK14;PRKAB1;ESR1;GRIN2B;NFKB1;PRKAG3;POMC;GRIN2A;MT-CO2;PGR;PPARG;PPARA;TP53;PPARD;MAPK3
Ion Channel Transport	5/184	0.03014224244385851	0.07868623784704054	0	0	2.9967640504319686	10.49415132508819	TRPA1;TRPV3;TRPM8;TRPV1;ASIC3
Acyl Chain Remodelling of PE	2/29	0.030217908830992755	0.07868623784704054	0	0	7.879330943847073	27.57230447704457	PLA2G2E;PLA2G2A
Activation of BH3-only Proteins	2/30	0.03217968496088416	0.08351898498071579	0	0	7.597542242703533	26.108345561861633	BCL2;TP53
Platelet Degranulation	4/128	0.03281040582720432	0.08487675474644002	0	0	3.4516129032258065	11.794194298359244	HSPA5;ALB;HABP4;ORM2
FOXO-mediated Transcription of Oxidative Stress, Metabolic and Neuronal Genes	2/31	0.03419020681101156	0.08701959088351005	0	0	7.335187245087134	24.762242659159735	POMC;NR3C1
Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	2/31	0.03419020681101156	0.08701959088351005	0	0	7.335187245087134	24.762242659159735	GRIA1;CACNG2
Trafficking of AMPA Receptors	2/31	0.03419020681101156	0.08701959088351005	0	0	7.335187245087134	24.762242659159735	GRIA1;CACNG2
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation	2/31	0.03419020681101156	0.08701959088351005	0	0	7.335187245087134	24.762242659159735	PPARG;PPARA
Transcriptional Regulation of Brown and Beige Adipocyte Differentiation by EBF2	2/31	0.03419020681101156	0.08701959088351005	0	0	7.335187245087134	24.762242659159735	PPARG;PPARA
ECM Proteoglycans	3/76	0.03485352202769631	0.08842260089984691	0	0	4.3848204368752315	14.718093033290018	VCAN;NCAN;HAPLN1
ESR-mediated Signaling	5/192	0.03524015109213121	0.08911692055029334	0	0	2.867391367873528	9.593056217192181	PDPK1;BCL2;PGR;ESR1;MAPK3
Nuclear Signaling by ERBB4	2/32	0.036248395206165566	0.09137375021618094	0	0	7.090322580645161	23.521153713231794	PGR;ESR1
Response to Elevated Platelet Cytosolic Ca2+	4/133	0.03697678399517122	0.09291300182226145	0	0	3.3169868554095046	10.937648137009278	HSPA5;ALB;HABP4;ORM2
Synthesis of Bile Acids and Bile Salts	2/33	0.03835318674200439	0.09576159601089071	0	0	6.861255636489767	22.373989663482092	AKR1C1;AKR1C3
TNFR1-induced NF-kappa-B Signaling Pathway	2/33	0.03835318674200439	0.09576159601089071	0	0	6.861255636489767	22.373989663482092	IKBKB;TNF
Fc Epsilon Receptor (FCERI) Signaling	5/197	0.03868141078426518	0.09627644513812375	0	0	2.7920081967213113	9.08071667024773	NFKBIA;IKBKB;PDPK1;NFKB1;MAPK3
MITF-M-regulated Melanocyte Development	4/136	0.03961632572837069	0.09776775960993647	0	0	3.241106719367589	10.463958353540802	POMC;BCL2;MAPK14;MAPK3
G Alpha (12 13) Signalling Events	3/80	0.039652323289201104	0.09776775960993647	0	0	4.156195156195156	13.414559333062375	ADRA1D;ADRA1B;ADRA1A
PKR-mediated Signaling	3/80	0.039652323289201104	0.09776775960993647	0	0	4.156195156195156	13.414559333062375	IKBKB;TUBB1;TP53
Senescence-Associated Secretory Phenotype (SASP)	3/81	0.040901756802268804	0.10053422466352052	0	0	4.102702702702703	13.114626690868452	RPS6KA3;NFKB1;MAPK3
Oncogene Induced Senescence	2/35	0.04269840344489658	0.10430043442112508	0	0	6.4447702834799605	20.324187282918963	TP53;MAPK3
Transcriptional Regulation by NPAS4	2/35	0.04269840344489658	0.10430043442112508	0	0	6.4447702834799605	20.324187282918963	NR3C1;MAPK3
Metabolism of Steroid Hormones	2/36	0.04493677898986669	0.10832069611227098	0	0	6.254901960784314	19.405825129162146	POMC;AKR1B1
Regulation of TP53 Degradation	2/36	0.04493677898986669	0.10832069611227098	0	0	6.254901960784314	19.405825129162146	PDPK1;TP53
Integrin Cell Surface Interactions	3/85	0.04609593654833912	0.10832069611227098	0	0	3.901779828609097	12.005895447767585	VCAM1;CD44;ICAM1
Activation of NOXA and Translocation to Mitochondria	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	TP53
Biosynthesis of E-series 18(S)-resolvins	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	ALOX5
Ciprofloxacin ADME	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	ALB
Dopamine Receptors	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	DRD2
MECP2 Regulates Transcription Factors	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	PPARG
NTRK2 Activates RAC1	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	NTRK2
PTK6 Expression	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	NR3C1
Regulation of NPAS4 Gene Transcription	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	NR3C1
Signalling to P38 via RIT and RIN	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	NTRK1
Tachykinin Receptors Bind Tachykinins	1/5	0.04612896564476939	0.10832069611227098	0	0	26.481283422459892	81.46474834004643	TACR3
NOD1 2 Signaling Pathway	2/37	0.047217658056508675	0.11022110120291523	0	0	6.075883256528418	18.549594691794358	IKBKB;MAPK14
Regulation of TP53 Expression and Degradation	2/37	0.047217658056508675	0.11022110120291523	0	0	6.075883256528418	18.549594691794358	PDPK1;TP53
Nuclear Events Mediated by NFE2L2	3/87	0.048809588541296405	0.11360107775540666	0	0	3.8084942084942086	11.500999348790215	PRKAA2;BCL2;NFKB1
FCERI Mediated NF-kB Activation	4/147	0.05019234843951792	0.11647577329052836	0	0	2.9901185770750986	8.946113899305418	NFKBIA;IKBKB;PDPK1;NFKB1
Formation of Fibrin Clot (Clotting Cascade)	2/39	0.05190299188180729	0.11939201339576079	0	0	5.74687590816623	17.00143610249925	THBD;C1QBP
Ovarian Tumor Domain Proteases	2/39	0.05190299188180729	0.11939201339576079	0	0	5.74687590816623	17.00143610249925	ESR1;TP53
Synthesis of PA	2/39	0.05190299188180729	0.11939201339576079	0	0	5.74687590816623	17.00143610249925	PLA2G2E;PLA2G2A
Vesicle-mediated Transport	12/752	0.05215891202303723	0.11963192321562897	0	0	1.7572481572481573	5.189962529162805	CHRM2;GRIA1;PRKAB2;PRKAA2;TUBB1;ALB;PRKAG1;STAB2;PRKAG2;PRKAB1;CFTR;PRKAG3
Opioid Signalling	3/90	0.05302347720647074	0.1212623870026244	0	0	3.6766076421248837	10.798272005637143	POMC;PDE4A;OPRM1
Class C 3 (Metabotropic Glutamate Pheromone Receptors)	2/40	0.054305515587317096	0.1217702687032995	0	0	5.595359366157329	16.300006326381972	GABBR2;GABBR1
Activated NTRK2 Signals Through CDK5	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	NTRK2
Biosynthesis of Lipoxins (LX)	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	ALOX5
Estrogen-stimulated Signaling Through PRKCZ	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	PDPK1
Metal Sequestration by Antimicrobial Proteins	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	LTF
Mtb Iron Assimilation by Chelation	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	LTF
Negative Feedback Regulation of MAPK Pathway	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	MAPK3
RUNX1 Regulates Estrogen Receptor Mediated Transcription	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	ESR1
RUNX1 Regulates Transcription of Genes Involved in WNT Signaling	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	ESR1
SLC15A4 TASL-dependent IRF5 Activation	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	IKBKB
Synthesis of 15-Eicosatetraenoic Acid Derivatives	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	PTGS2
TNFR1-mediated Ceramide Production	1/6	0.05509757405206327	0.1217702687032995	0	0	21.183957219251337	61.40486894810826	TNF
Metabolism of Carbohydrates	6/290	0.056604149542667744	0.12402529304111692	0	0	2.2668317597895062	6.509599521561242	VCAN;NCAN;STAB2;AKR1B1;HMMR;CD44
Diseases Associated With Glycosaminoglycan Metabolism	2/41	0.05674668033947176	0.12402529304111692	0	0	5.451612903225806	15.641539431398336	VCAN;NCAN
Signaling by Retinoic Acid	2/41	0.05674668033947176	0.12402529304111692	0	0	5.451612903225806	15.641539431398336	AKR1C3;PPARD
Transcriptional Regulation by VENTX	2/41	0.05674668033947176	0.12402529304111692	0	0	5.451612903225806	15.641539431398336	TP53;NFKB1
Oxidative Stress Induced Senescence	3/94	0.058904985054347714	0.12837627425888823	0	0	3.5142857142857142	9.951858153973667	MAPK14;TP53;MAPK3
tRNA Aminoacylation	2/42	0.05922555618534261	0.12837627425888823	0	0	5.315053763440861	15.022479320173026	WARS1;WARS2
EPHB-mediated Forward Signaling	2/42	0.05922555618534261	0.12837627425888823	0	0	5.315053763440861	15.022479320173026	GRIN2B;GRIN1
Death Receptor Signaling	4/157	0.06102354813037329	0.13191117664346447	0	0	2.7932651321398123	7.8113532448987115	NFKBIA;IKBKB;TNF;NFKB1
Aggrephagy	2/43	0.061741227067090364	0.13237453303243013	0	0	5.1851560451088385	14.439640108014142	TUBB1;CFTR
Aspirin ADME	2/43	0.061741227067090364	0.13237453303243013	0	0	5.1851560451088385	14.439640108014142	ALB;CES1
Transport of Vitamins, Nucleosides, and Related Molecules	2/43	0.061741227067090364	0.13237453303243013	0	0	5.1851560451088385	14.439640108014142	SLC29A1;SLC29A2
Antiviral Mechanism by IFN-stimulated Genes	4/158	0.06216966353380595	0.13293188219017044	0	0	2.774985883681536	7.708600327078361	IKBKB;TUBB1;TP53;MAPK3
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers	8/451	0.06355828561762054	0.1339046074267855	0	0	1.9432154502131929	5.355109077036207	NTRK2;PDPK1;FGF1;FGF2;TP53;ESR1;FGF4;MAPK3
ARMS-mediated Activation	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	NTRK1
Activated NTRK2 Signals Through PI3K	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	NTRK2
CREB Phosphorylation	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	RPS6KA3
FGFR3b Ligand Binding and Activation	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	FGF1
Fructose Metabolism	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	AKR1B1
RUNX3 Regulates CDKN1A Transcription	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	TP53
Signaling by LTK in Cancer	1/7	0.06398230291495328	0.1339046074267855	0	0	17.6524064171123	48.52909105046853	MAPK3
P75 NTR Receptor-Mediated Signalling	3/98	0.0650799326217689	0.13584144666289857	0	0	3.365633001422475	9.19537729039115	NFKBIA;IKBKB;NFKB1
Disease	27/2131	0.06660238913388421	0.13842496568250146	0	0	1.411437545757268	3.8236052419433624	NCAN;LY96;CXCR4;FGF1;NR3C1;FGF2;SLC6A2;SLC6A3;FGF4;IKBKB;C1QBP;TUBB1;MAPK3;NTRK2;PDPK1;SIGMAR1;MAPK14;ESR1;NFKB1;NFKB2;NFKBIA;POMC;VCAN;IL1B;TP53;CFTR;LTF
Visual Phototransduction	3/99	0.06666855127927826	0.13842496568250146	0	0	3.3304054054054055	9.018810881330282	AKR1B10;AKR1C1;AKR1C3
PKMTs Methylate Histone Lysines	2/46	0.06950005415400462	0.1439253089960883	0	0	4.83088954056696	12.881217914709978	NFKB1;NFKB2
Heme Signaling	2/47	0.07215401649767117	0.14800650103925808	0	0	4.7232974910394265	12.417323928284068	LY96;PPARA
Biosynthesis of Maresins	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	ALOX5
Formation of Intermediate Mesoderm	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	FGF2
IFNG Signaling Activates MAPKs	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	MAPK3
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs IMPs VICKZs) Bind RNA	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	CD44
Interleukin-18 Signaling	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	ALOX5
Regulation of NFE2L2 Gene Expression	1/8	0.07278393207000271	0.14800650103925808	0	0	15.12987012987013	39.64419443644198	NFKB1
Membrane Trafficking	10/633	0.07628936083024852	0.15473600435749635	0	0	1.7303911843742674	4.452680299253627	CHRM2;GRIA1;PRKAB2;PRKAA2;TUBB1;PRKAG1;PRKAG2;PRKAB1;CFTR;PRKAG3
Phase I - Functionalization of Compounds	3/105	0.07656667538369553	0.15490027404547635	0	0	3.133545310015898	8.051937172072444	POMC;CES1;PTGS1
Transcriptional Regulation by RUNX2	3/106	0.07827609100840353	0.15795354425992428	0	0	3.1029651010233534	7.904844162155379	NR3C1;ESR1;MAPK3
Chondroitin Sulfate Dermatan Sulfate Metabolism	2/50	0.08030707404949645	0.15956836694476326	0	0	4.42741935483871	11.165498097498467	VCAN;NCAN
Regulation of TNFR1 Signaling	2/50	0.08030707404949645	0.15956836694476326	0	0	4.42741935483871	11.165498097498467	IKBKB;TNF
Activated NTRK2 Signals Through RAS	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	NTRK2
Activation of PUMA and Translocation to Mitochondria	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	TP53
BH3-only Proteins Associate With and Inactivate Anti-Apoptotic BCL-2 Members	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	BCL2
CD163 Mediating an Anti-Inflammatory Response	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	MAPK14
Ca2+ Activated K+ Channels	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	KCNMA1
PI3K AKT Activation	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	NTRK1
PI5P Regulates TP53 Acetylation	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	TP53
Phase 3 - Rapid Repolarisation	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	KCNH2
Synthesis of 5-Eicosatetraenoic Acids	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	ALOX5
TRIF-mediated Programmed Cell Death	1/9	0.08150323432032902	0.15956836694476326	0	0	13.237967914438503	33.18907582058219	LY96
Leishmania Infection	5/245	0.08193232864602314	0.15961631432521545	0	0	2.228142076502732	5.574503173734402	IL1B;MAPK14;NFKB1;NFKB2;MAPK3
Parasitic Infection Pathways	5/245	0.08193232864602314	0.15961631432521545	0	0	2.228142076502732	5.574503173734402	IL1B;MAPK14;NFKB1;NFKB2;MAPK3
Transcriptional and Post-Translational Regulation of MITF-M Expression and Activity	2/51	0.08308573799591817	0.16146464846990008	0	0	4.336844415185429	10.78955809604069	POMC;MAPK3
SLC-mediated Transmembrane Transport	5/249	0.08636648453071355	0.16742790244406142	0	0	2.1911672489474157	5.366509514090389	SLC15A1;SLC29A1;SLC6A2;SLC6A3;SLC29A2
SARS-CoV-1-host Interactions	3/112	0.0888773322396754	0.17055450738189618	0	0	2.9312670468633772	7.095126462348807	NFKBIA;PDPK1;NFKB1
ATF6 (ATF6-alpha) Activates Chaperone Genes	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	HSPA5
Acetylcholine Regulates Insulin Secretion	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	CHRM3
Activation of Ca-permeable Kainate Receptor	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	GRIK2
Glucocorticoid Biosynthesis	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	POMC
HDL Remodeling	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	ALB
Ionotropic Activity of Kainate Receptors	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	GRIK2
MAPK3 (ERK1) Activation	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	MAPK3
RHOBTB3 ATPase Cycle	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	HTR7
Signal Attenuation	1/10	0.09014097538434816	0.17055450738189618	0	0	11.766488413547236	28.314647577691105	MAPK3
SARS-CoV-1 Activates Modulates Innate Immune Responses	2/54	0.09159348184787752	0.1728881750669267	0	0	4.086021505376344	9.76720606565563	NFKBIA;NFKB1
Activated NTRK2 Signals Through FRS2 and FRS3	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	NTRK2
Androgen Biosynthesis	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	POMC
Formation of Apoptosome	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	MAPK3
NFE2L2 Regulating Tumorigenic Genes	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	BCL2
Regulated Proteolysis of p75NTR	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	NFKB1
Regulation of the Apoptosome Activity	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	MAPK3
Ribavirin ADME	1/11	0.09869791397691897	0.18322977441832722	0	0	10.589304812834225	24.521562804501926	SLC29A1
Heparan Sulfate Heparin (HS-GAG) Metabolism	2/57	0.1003427156548933	0.18584601561434463	0	0	3.8625610948191595	8.880660628129885	VCAN;NCAN
KEAP1-NFE2L2 Pathway	3/119	0.10195908063436109	0.18839745812766018	0	0	2.7534016775396086	6.286521874975749	PRKAA2;BCL2;NFKB1
Gastrulation	3/120	0.10388762745584298	0.19151247210901895	0	0	2.72972972972973	6.1813241187352785	CXCR4;FGF2;FGF4
Estrogen-dependent Gene Expression	3/121	0.10583061063317406	0.1926216825689463	0	0	2.7064590013742555	6.078478156208309	BCL2;PGR;ESR1
Regulation of RUNX2 Expression and Activity	2/59	0.10629980472412343	0.1926216825689463	0	0	3.7266553480475384	8.353267518341566	NR3C1;ESR1
TNF Signaling	2/59	0.10629980472412343	0.1926216825689463	0	0	3.7266553480475384	8.353267518341566	IKBKB;TNF
ATF6 (ATF6-alpha) Activates Chaperones	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	HSPA5
Binding and Entry of HIV Virion	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	CXCR4
Peptide Hormone Biosynthesis	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	POMC
Pregnenolone Biosynthesis	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	AKR1B1
Specification of Primordial Germ Cells	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	CXCR4
Suppression of Apoptosis	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	MAPK3
TP53 Regulates Transcription of Caspase Activators and Caspases	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	TP53
TP53 Regulates Transcription of Death Receptors and Ligands	1/12	0.1071748018349397	0.1926216825689463	0	0	9.626154594069032	21.49803440968974	TP53
Regulated Necrosis	2/61	0.11234964678239731	0.20146334388934428	0	0	3.599963550209586	7.870022243010862	IL1B;TP53
p38MAPK Events	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	MAPK14
p75NTR Recruits Signalling Complexes	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	IKBKB
Advanced Glycosylation Endproduct Receptor Signaling	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	MAPK3
Cytochrome C-Mediated Apoptotic Response	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	MAPK3
Dissolution of Fibrin Clot	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	PLAT
ERKs Are Inactivated	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	MAPK3
NF-kB Activation Through FADD RIP-1 Pathway Mediated by Caspase-8 and -10	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	IKBKB
POU5F1 (OCT4), SOX2, NANOG Activate Genes Related to Proliferation	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	FGF2
TFAP2 (AP-2) Family Regulates Transcription of Growth Factors and Their Receptors	1/13	0.11557238377274692	0.20308822003718782	0	0	8.823529411764707	19.03992569985146	ESR1
Metabolism of Vitamins and Cofactors	4/198	0.11688068680272723	0.20493080419411508	0	0	2.1983415508740474	4.718963568320985	AKR1B10;AKR1C1;AKR1C3;PTGS2
Golgi Cisternae Pericentriolar Stack Reorganization	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	MAPK3
Heme Biosynthesis	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	ALB
IRAK1 Recruits IKK Complex	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	IKBKB
IRAK1 Recruits IKK Complex Upon TLR7 8 or 9 Stimulation	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	IKBKB
LGI-ADAM Interactions	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	CACNG2
Physiological Factors	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	CES1
Regulation of NPAS4 Gene Expression	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	NR3C1
Regulation of TBK1, IKK? (IKBKE)-mediated Activation of IRF3, IRF7	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	LY96
Regulation of TP53 Activity Through Association With Co-factors	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	TP53
Retrograde Neurotrophin Signalling	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	NTRK1
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	TP53
TP53 Regulates Transcription of Cell Death Genes With Uncertain Role in P53-Dependent Apoptosis	1/14	0.12389139769145668	0.21158076358995526	0	0	8.144385026737968	17.008325836994665	TP53
The Role of GTSE1 in G2 M Progression After G2 Checkpoint	2/65	0.12470572202486312	0.21251147878534987	0	0	3.3707117255504353	7.017142752459354	TUBB1;TP53
FOXO-mediated Transcription	2/67	0.13100144614942302	0.22275892459460078	0	0	3.2666666666666666	6.639653260675596	POMC;NR3C1
Activation of BAD and Translocation to Mitochondria	1/15	0.1321325747592745	0.22276196898518716	0	0	7.562261268143621	15.305634959302008	BCL2
IRAK2 Mediated Activation of TAK1 Complex Upon TLR7 8 or 9 Stimulation	1/15	0.1321325747592745	0.22276196898518716	0	0	7.562261268143621	15.305634959302008	LY96
Phase 2 - Plateau Phase	1/15	0.1321325747592745	0.22276196898518716	0	0	7.562261268143621	15.305634959302008	CACNB1
SARS-CoV-2 Targets Host Intracellular Signalling and Regulatory Pathways	1/15	0.1321325747592745	0.22276196898518716	0	0	7.562261268143621	15.305634959302008	PDPK1
Sensory Processing of Sound by Inner Hair Cells of the Cochlea	2/69	0.1373688964062869	0.2310960751909603	0	0	3.168833253089392	6.2904043006482215	KCNMA1;CACNA1D
RHO GTPase Effectors	5/291	0.14007841313177247	0.23350745248985338	0	0	1.8653750620963736	3.666493399020623	PDPK1;TUBB1;MAPK14;CFTR;MAPK3
cGMP Effects	1/16	0.14029663931929506	0.23350745248985338	0	0	7.057754010695187	13.861402380035642	KCNMA1
Heme Degradation	1/16	0.14029663931929506	0.23350745248985338	0	0	7.057754010695187	13.861402380035642	ALB
Spry Regulation of FGF Signaling	1/16	0.14029663931929506	0.23350745248985338	0	0	7.057754010695187	13.861402380035642	MAPK3
TRAF6-mediated Induction of TAK1 Complex Within TLR4 Complex	1/16	0.14029663931929506	0.23350745248985338	0	0	7.057754010695187	13.861402380035642	LY96
Circadian Clock	2/70	0.14057799737982302	0.23350745248985338	0	0	3.1220746363061354	6.125487966077742	NR3C1;PPARA
Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	TP53
KSRP (KHSRP) Binds and Destabilizes mRNA	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	MAPK14
Metabolism of Angiotensinogen to Angiotensins	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	CES1
Platelet Sensitization by LDL	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	MAPK14
Signaling by Activin	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	MAPK3
Specification of the Neural Plate Border	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	FGF4
Trafficking of GluR2-containing AMPA Receptors	1/17	0.14838430903089075	0.24289464694060747	0	0	6.616310160427807	12.623586907174872	GRIA1
PTEN Regulation	3/145	0.15635166215748725	0.25080625348838753	0	0	2.2462885420631897	4.168319861414304	PPARG;TP53;MAPK3
Zygotic Genome Activation (ZGA)	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	TP53
Activation of IRF3, IRF7 Mediated by TBK1, IKK? (IKBKE)	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	LY96
Caspase Activation via Death Receptors in the Presence of Ligand	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	LY96
Formation of Definitive Endoderm	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	CXCR4
Formation of the Nephric Duct	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	FGF2
Mitochondrial Unfolded Protein Response (UPRmt)	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	ESR1
RORA Activates Gene Expression	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	PPARA
Recycling of Bile Acids and Salts	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	ALB
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1/18	0.15639629495093366	0.25080625348838753	0	0	6.22680088078012	11.552970612023577	TP53
Biological Oxidations	4/222	0.15708164261559776	0.25139435298926294	0	0	1.9539289988033506	3.616702240557284	POMC;GSTP1;CES1;PTGS1
FASTK Family Proteins Regulate Processing and Stability of Mitochondrial RNAs	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	MT-CO2
Microtubule-dependent Trafficking of Connexons From Golgi to the Plasma Membrane	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	TUBB1
MyD88 Deficiency (TLR2 4)	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	LY96
Nicotinamide Salvaging	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	PTGS2
Regulation of MITF-M-dependent Genes Involved in Apoptosis	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	BCL2
Regulation of TP53 Activity Through Methylation	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	TP53
SARS-CoV-1 Targets Host Intracellular Signalling and Regulatory Pathways	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	PDPK1
TICAM1, RIP1-mediated IKK Complex Recruitment	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	IKBKB
VEGFR2 Mediated Cell Proliferation	1/19	0.16433330155550302	0.2582848106121352	0	0	5.880570409982175	10.619478571217373	PDPK1
Diseases of Programmed Cell Death	2/78	0.16678359478402202	0.26109574659641543	0	0	2.792303338992643	5.001177642824829	C1QBP;TP53
Regulation of Insulin Secretion	2/78	0.16678359478402202	0.26109574659641543	0	0	2.792303338992643	5.001177642824829	CHRM3;CACNA1D
IRAK4 Deficiency (TLR2 4)	1/20	0.17219602675220333	0.2669207565962444	0	0	5.570785251899803	9.799689560820283	LY96
SUMOylation of Transcription Factors	1/20	0.17219602675220333	0.2669207565962444	0	0	5.570785251899803	9.799689560820283	TP53
Synthesis of Leukotrienes (LT) and Eoxins (EX)	1/20	0.17219602675220333	0.2669207565962444	0	0	5.570785251899803	9.799689560820283	ALOX5
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1/20	0.17219602675220333	0.2669207565962444	0	0	5.570785251899803	9.799689560820283	TP53
Transport of Connexons to the Plasma Membrane	1/20	0.17219602675220333	0.2669207565962444	0	0	5.570785251899803	9.799689560820283	TUBB1
ER-Phagosome Pathway	2/80	0.17346291123633858	0.2683573273832768	0	0	2.7204301075268815	4.765626258558041	IKBKB;LY96
CD209 (DC-SIGN) Signaling	1/21	0.17998516202793857	0.2760505577348421	0	0	5.2919786096256685	9.075112853878617	NFKB1
ER Quality Control Compartment (ERQC)	1/21	0.17998516202793857	0.2760505577348421	0	0	5.2919786096256685	9.075112853878617	TRIM13
Mitochondrial tRNA Aminoacylation	1/21	0.17998516202793857	0.2760505577348421	0	0	5.2919786096256685	9.075112853878617	WARS2
TP53 Regulates Transcription of Additional Cell Cycle Genes With Uncertain Roles in the P53 Pathway	1/21	0.17998516202793857	0.2760505577348421	0	0	5.2919786096256685	9.075112853878617	TP53
Infection With Mycobacterium Tuberculosis	2/82	0.18018509155062573	0.2760505577348421	0	0	2.6521505376344088	4.545177803885877	LTF;MAPK3
Regulation of HSF1-mediated Heat Shock Response	2/83	0.1835610274310034	0.28067761752531334	0	0	2.6192751891676624	4.440216496434102	HSPA5;MAPK3
SARS-CoV-1 Infection	3/157	0.18395545871033825	0.2807366671614253	0	0	2.06998946998947	3.504619731454117	NFKBIA;PDPK1;NFKB1
Transport of Bile Salts and Organic Acids, Metal Ions and Amine Compounds	2/84	0.1869462217863541	0.2820883784166412	0	0	2.5872016784683978	4.338567203347671	SLC6A2;SLC6A3
Chaperone Mediated Autophagy	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	CFTR
Common Pathway of Fibrin Clot Formation	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	THBD
Early Phase of HIV Life Cycle	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	CXCR4
NPAS4 Regulates Expression of Target Genes	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	MAPK3
Post-chaperonin Tubulin Folding Pathway	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	TUBB1
RA Biosynthesis Pathway	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	AKR1C3
Regulation of TLR by Endogenous Ligand	1/22	0.1877013924825559	0.2820883784166412	0	0	5.039724980901451	8.430970620202137	LY96
Peptide Hormone Metabolism	2/86	0.19374251800745163	0.29025897951483276	0	0	2.525345622119816	4.144660945023376	POMC;CES1
Activated TAK1 Mediates P38 MAPK Activation	1/23	0.1953453968597924	0.29025897951483276	0	0	4.810403500243073	7.855321672768903	MAPK14
Intrinsic Pathway of Fibrin Clot Formation	1/23	0.1953453968597924	0.29025897951483276	0	0	4.810403500243073	7.855321672768903	C1QBP
Nitric Oxide Stimulates Guanylate Cyclase	1/23	0.1953453968597924	0.29025897951483276	0	0	4.810403500243073	7.855321672768903	KCNMA1
RAF-independent MAPK1 3 Activation	1/23	0.1953453968597924	0.29025897951483276	0	0	4.810403500243073	7.855321672768903	MAPK3
Signaling by NODAL	1/23	0.1953453968597924	0.29025897951483276	0	0	4.810403500243073	7.855321672768903	MAPK3
Signaling by the B Cell Receptor (BCR)	3/162	0.19581913978603155	0.290415979870637	0	0	2.004385517593065	3.268278470133887	NFKBIA;IKBKB;NFKB1
Platelet Homeostasis	2/87	0.19715270560572906	0.2918451870974113	0	0	2.4955091714104998	4.05214963510157	KCNMA1;MAPK14
TNFR2 Non-Canonical NF-kB Pathway	2/88	0.20057032288764085	0.29586302267053083	0	0	2.466366591647912	3.962440780835938	TNF;NFKB2
Disorders of Transmembrane Transporters	3/164	0.20061687849015716	0.29586302267053083	0	0	1.9792848749370489	3.179440621530316	SLC6A2;CFTR;SLC6A3
CD28 Dependent PI3K Akt Signaling	1/24	0.2029178475987033	0.29648552176921644	0	0	4.601023017902813	7.338420404589049	PDPK1
Cytosolic tRNA Aminoacylation	1/24	0.2029178475987033	0.29648552176921644	0	0	4.601023017902813	7.338420404589049	WARS1
DARPP-32 Events	1/24	0.2029178475987033	0.29648552176921644	0	0	4.601023017902813	7.338420404589049	PDE4A
Growth Hormone Receptor Signaling	1/24	0.2029178475987033	0.29648552176921644	0	0	4.601023017902813	7.338420404589049	MAPK3
RUNX2 Regulates Osteoblast Differentiation	1/24	0.2029178475987033	0.29648552176921644	0	0	4.601023017902813	7.338420404589049	MAPK3
ADP Signalling Through P2Y Purinoceptor 1	1/25	0.21041941094992814	0.304625532549529	0	0	4.409090909090909	6.8722407666237695	MAPK14
Basigin Interactions	1/25	0.21041941094992814	0.304625532549529	0	0	4.409090909090909	6.8722407666237695	L1CAM
Formation of Tubulin Folding Intermediates by CCT TriC	1/25	0.21041941094992814	0.304625532549529	0	0	4.409090909090909	6.8722407666237695	TUBB1
G Beta Gamma Signalling Through PI3Kgamma	1/25	0.21041941094992814	0.304625532549529	0	0	4.409090909090909	6.8722407666237695	PDPK1
Mitochondrial RNA Degradation	1/25	0.21041941094992814	0.304625532549529	0	0	4.409090909090909	6.8722407666237695	MT-CO2
Chaperonin-mediated Protein Folding	2/91	0.21086341071973488	0.3047092143917048	0	0	2.3828681889573518	3.7090408447996106	TUBB1;TP53
EPH-Ephrin Signaling	2/92	0.21430644168613416	0.30911843234069447	0	0	2.3562724014336918	3.629480229724129	GRIN2B;GRIN1
Signaling by ALK Fusions and Activated Point Mutants	2/93	0.21775478653871236	0.3108214093685526	0	0	2.3302611367127497	3.5522167113873317	TP53;MAPK3
Signaling by ALK in Cancer	2/93	0.21775478653871236	0.3108214093685526	0	0	2.3302611367127497	3.5522167113873317	TP53;MAPK3
Calnexin Calreticulin Cycle	1/26	0.21785074699722382	0.3108214093685526	0	0	4.232513368983957	6.450117998649596	TRIM13
Constitutive Signaling by AKT1 E17K in Cancer	1/26	0.21785074699722382	0.3108214093685526	0	0	4.232513368983957	6.450117998649596	PDPK1
Endogenous Sterols	1/26	0.21785074699722382	0.3108214093685526	0	0	4.232513368983957	6.450117998649596	POMC
TNFR1-induced Proapoptotic Signaling	1/26	0.21785074699722382	0.3108214093685526	0	0	4.232513368983957	6.450117998649596	TNF
MITF-M-dependent Gene Expression	2/94	0.22120804381033063	0.3150417808056875	0	0	2.3048153342683495	3.4771634467842025	BCL2;MAPK14
Antimicrobial Peptides	2/95	0.224665818985112	0.31844564535039993	0	0	2.279916753381894	3.4042377050053183	PLA2G2A;LTF
Integrin Signaling	1/27	0.22521250963944633	0.31844564535039993	0	0	4.06951871657754	6.066475645009069	PDPK1
Prefoldin Mediated Transfer of Substrate to CCT TriC	1/27	0.22521250963944633	0.31844564535039993	0	0	4.06951871657754	6.066475645009069	TUBB1
Syndecan Interactions	1/27	0.22521250963944633	0.31844564535039993	0	0	4.06951871657754	6.066475645009069	FGF2
Antigen processing-Cross Presentation	2/96	0.2281277245244306	0.3219906523251802	0	0	2.2555479295355756	3.3333606316001045	IKBKB;LY96
Protein Folding	2/97	0.23159337968630597	0.3252601394760577	0	0	2.2316921335597057	3.2644570307419456	TUBB1;TP53
Adrenaline,noradrenaline Inhibits Insulin Secretion	1/28	0.23250534684980548	0.3252601394760577	0	0	3.918597742127154	5.716615190741829	CACNA1D
BMAL1 CLOCK,NPAS2 Activates Circadian Gene Expression	1/28	0.23250534684980548	0.3252601394760577	0	0	3.918597742127154	5.716615190741829	PPARA
Caspase Activation via Extrinsic Apoptotic Signalling Pathway	1/28	0.23250534684980548	0.3252601394760577	0	0	3.918597742127154	5.716615190741829	LY96
Metabolism of Porphyrins	1/28	0.23250534684980548	0.3252601394760577	0	0	3.918597742127154	5.716615190741829	ALB
SLC Transporter Disorders	2/99	0.23853444920891423	0.33251533644140163	0	0	2.1854561578538965	3.1322865448197508	SLC6A2;SLC6A3
VEGFA-VEGFR2 Pathway	2/99	0.23853444920891423	0.33251533644140163	0	0	2.1854561578538965	3.1322865448197508	PDPK1;MAPK14
Myogenesis	1/29	0.23972990045350298	0.3330050905947427	0	0	3.7784568372803666	5.396552277337301	MAPK14
VEGFR2 Mediated Vascular Permeability	1/29	0.23972990045350298	0.3330050905947427	0	0	3.7784568372803666	5.396552277337301	PDPK1
Deubiquitination	4/268	0.24532686133674086	0.3398044634340232	0	0	1.609683794466403	2.261869445222717	NFKBIA;TP53;ESR1;CFTR
Cellular Response to Heat Stress	2/101	0.2454861142679255	0.3398044634340232	0	0	2.141088302378625	3.0071904108606726	HSPA5;MAPK3
Activation of Kainate Receptors Upon Glutamate Binding	1/30	0.24688680646296318	0.3399540842919336	0	0	3.6479808224230132	5.102887944281363	GRIK2
Paracetamol ADME	1/30	0.24688680646296318	0.3399540842919336	0	0	3.6479808224230132	5.102887944281363	GSTP1
Regulation of TP53 Activity Through Acetylation	1/30	0.24688680646296318	0.3399540842919336	0	0	3.6479808224230132	5.102887944281363	TP53
G2 M Transition	3/184	0.24992034159122364	0.3435316193649398	0	0	1.7587875167985665	2.4387577151072897	TUBB1;HMMR;TP53
Antigen Presentation Folding, Assembly and Peptide Loading of Class I MHC	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	HSPA5
Downregulation of SMAD2 3 SMAD4 Transcriptional Activity	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	MAPK3
Nicotinate Metabolism	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	PTGS2
RHO GTPases Activate IQGAPs	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	TUBB1
RNA Polymerase I Promoter Opening	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	MAPK3
RUNX2 Regulates Bone Development	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	MAPK3
Sealing of the Nuclear Envelope (NE) by ESCRT-III	1/31	0.2539766948759526	0.34490122591588057	0	0	3.52620320855615	4.832706522110258	TUBB1
Mitotic G2-G2 M Phases	3/186	0.2549561666486708	0.34552753552514637	0	0	1.7393885688967656	2.3771591200653686	TUBB1;HMMR;TP53
Sensory Perception	8/640	0.2553137556541956	0.34552753552514637	0	0	1.348804500703235	1.8414716325228573	AKR1B10;AKR1C1;KCNMA1;CHRNA9;AKR1C3;CHRNA10;CACNA1D;SCN2A
Cargo Recognition for Clathrin-Mediated Endocytosis	2/105	0.2594100908719963	0.3496250422381844	0	0	2.0575216619688903	2.776306787204791	CHRM2;CFTR
Cooperation of Prefoldin and TriC CCT in Actin and Tubulin Folding	1/32	0.26100018995981067	0.3496250422381844	0	0	3.4122822149387613	4.583493979538542	TUBB1
G-protein Beta Gamma Signalling	1/32	0.26100018995981067	0.3496250422381844	0	0	3.4122822149387613	4.583493979538542	PDPK1
Respiratory Syncytial Virus (RSV) Attachment and Entry	1/32	0.26100018995981067	0.3496250422381844	0	0	3.4122822149387613	4.583493979538542	LY96
Thrombin Signalling Through Proteinase Activated Receptors (PARs)	1/32	0.26100018995981067	0.3496250422381844	0	0	3.4122822149387613	4.583493979538542	MAPK3
Transcriptional Regulation of Pluripotent Stem Cells	1/32	0.26100018995981067	0.3496250422381844	0	0	3.4122822149387613	4.583493979538542	FGF2
Ub-specific Processing Proteases	3/190	0.2650699576111923	0.35447490941564525	0	0	1.701835525364937	2.259631684550668	NFKBIA;TP53;CFTR
Post-translational Protein Phosphorylation	2/107	0.2663770805001078	0.35562016330725044	0	0	2.018125960061444	2.6696625444660165	VCAN;ALB
Cargo Concentration in the ER	1/33	0.26795791016557285	0.35592389077548314	0	0	3.30548128342246	4.353072137164059	GRIA1
PERK Regulates Gene Expression	1/33	0.26795791016557285	0.35592389077548314	0	0	3.30548128342246	4.353072137164059	HSPA5
Signal Amplification	1/33	0.26795791016557285	0.35592389077548314	0	0	3.30548128342246	4.353072137164059	MAPK14
Signaling by VEGF	2/108	0.26986070890691527	0.3578489064328675	0	0	1.9989855954554676	2.618369974950044	PDPK1;MAPK14
Late Endosomal Microautophagy	1/34	0.2748504681880484	0.3632445886103354	0	0	3.205153135634419	4.139545279364816	CFTR
Plasma Lipoprotein Remodeling	1/34	0.2748504681880484	0.3632445886103354	0	0	3.205153135634419	4.139545279364816	ALB
CD28 Co-Stimulation	1/35	0.28167847106114263	0.3691766007761487	0	0	3.110726643598616	3.9412565392335632	PDPK1
GPVI-mediated Activation Cascade	1/35	0.28167847106114263	0.3691766007761487	0	0	3.110726643598616	3.9412565392335632	PDPK1
Latent Infection - Other Responses of Mtb to Phagocytosis	1/35	0.28167847106114263	0.3691766007761487	0	0	3.110726643598616	3.9412565392335632	LTF
N-glycan Trimming in the ER and Calnexin Calreticulin Cycle	1/35	0.28167847106114263	0.3691766007761487	0	0	3.110726643598616	3.9412565392335632	TRIM13
Nuclear Events Stimulated by ALK Signaling in Cancer	1/35	0.28167847106114263	0.3691766007761487	0	0	3.110726643598616	3.9412565392335632	MAPK3
Detoxification of Reactive Oxygen Species	1/36	0.28844252019989663	0.3749277568990419	0	0	3.021695951107716	3.756752045112455	GSTP1
RHO GTPases Activate WASPs and WAVEs	1/36	0.28844252019989663	0.3749277568990419	0	0	3.021695951107716	3.756752045112455	MAPK3
SMAD2 SMAD3 SMAD4 Heterotrimer Regulates Transcription	1/36	0.28844252019989663	0.3749277568990419	0	0	3.021695951107716	3.756752045112455	MAPK3
Signaling by High-Kinase Activity BRAF Mutants	1/36	0.28844252019989663	0.3749277568990419	0	0	3.021695951107716	3.756752045112455	MAPK3
Transcriptional Regulation by the AP-2 (TFAP2) Family of Transcription Factors	1/36	0.28844252019989663	0.3749277568990419	0	0	3.021695951107716	3.756752045112455	ESR1
Gap Junction Assembly	1/37	0.29514321141622285	0.3817508095203276	0	0	2.9376114081996434	3.5847512737357596	TUBB1
Gene and Protein Expression by JAK-STAT Signaling After Interleukin-12 Stimulation	1/37	0.29514321141622285	0.3817508095203276	0	0	2.9376114081996434	3.5847512737357596	CA1
Glutathione Conjugation	1/37	0.29514321141622285	0.3817508095203276	0	0	2.9376114081996434	3.5847512737357596	GSTP1
PPARA Activates Gene Expression	2/117	0.30116406069024587	0.38890089015483464	0	0	1.8417017297802711	2.2102264495889106	PPARG;PPARA
rRNA Processing in the Mitochondrion	1/38	0.3017811351130041	0.38906097320941213	0	0	2.8580719757190347	3.42412239784083	MT-CO2
Regulation of Lipid Metabolism by PPARalpha	2/119	0.3080961159795572	0.39431697758558326	0	0	1.810035842293907	2.1310338971688236	PPARG;PPARA
Association of TriC CCT With Target Proteins During Biosynthesis	1/39	0.30835687600799094	0.39431697758558326	0	0	2.7827188291584575	3.273861685690662	TP53
Autodegradation of the E3 Ubiquitin Ligase COP1	1/39	0.30835687600799094	0.39431697758558326	0	0	2.7827188291584575	3.273861685690662	TP53
Platelet Aggregation (Plug Formation)	1/39	0.30835687600799094	0.39431697758558326	0	0	2.7827188291584575	3.273861685690662	PDPK1
Response of Mtb to Phagocytosis	1/39	0.30835687600799094	0.39431697758558326	0	0	2.7827188291584575	3.273861685690662	MAPK3
MAP2K and MAPK Activation	1/40	0.3148710136284463	0.40199551739942413	0	0	2.7112299465240643	3.1330761909760083	MAPK3
Binding and Uptake of Ligands by Scavenger Receptors	2/122	0.31846865054539186	0.4059317694350794	0	0	1.764516129032258	2.019014473458208	ALB;STAB2
Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste	1/41	0.3213241220283002	0.40825238692484517	0	0	2.6433155080213906	3.000969152484384	SCN2A
Signaling by RAF1 Mutants	1/41	0.3213241220283002	0.40825238692484517	0	0	2.6433155080213906	3.000969152484384	MAPK3
Regulation of IGF Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	2/124	0.3253638662019889	0.41272040262599563	0	0	1.7354133615371057	1.9485414454851493	VCAN;ALB
SARS-CoV Infections	6/498	0.327295307702022	0.4137096502479974	0	0	1.2945590994371483	1.4458832634757144	NFKBIA;IKBKB;PDPK1;SIGMAR1;NR3C1;NFKB1
tRNA Processing in the Mitochondrion	1/42	0.32771676984156956	0.4137096502479974	0	0	2.5787139689578713	2.8768276161867217	MT-CO2
Regulation of MITF-M-dependent Genes Involved in Pigmentation	1/42	0.32771676984156956	0.4137096502479974	0	0	2.5787139689578713	2.8768276161867217	MAPK14
Activation of Gene Expression by SREBF (SREBP)	1/43	0.3340495206858627	0.4203589662219229	0	0	2.517188693659282	2.760011897395603	PPARA
Negative Regulation of MAPK Pathway	1/43	0.3340495206858627	0.4203589662219229	0	0	2.517188693659282	2.760011897395603	MAPK3
Glycerophospholipid Biosynthesis	2/128	0.33909865924576893	0.4260331881288403	0	0	1.6799795186891961	1.8168376788442873	PLA2G2E;PLA2G2A
Stabilization of P53	1/44	0.34032293266577135	0.42621395852903743	0	0	2.4585250590722545	2.6499465827821207	TP53
TP53 Regulates Transcription of Cell Death Genes	1/44	0.34032293266577135	0.42621395852903743	0	0	2.4585250590722545	2.6499465827821207	TP53
Carboxyterminal Post-Translational Modifications of Tubulin	1/45	0.34653755892445787	0.4305797385691295	0	0	2.4025279533300923	2.5461128046616652	TUBB1
Paradoxical Activation of RAF Signaling by Kinase Inactive BRAF	1/45	0.34653755892445787	0.4305797385691295	0	0	2.4025279533300923	2.5461128046616652	MAPK3
Signaling by RAS Mutants	1/45	0.34653755892445787	0.4305797385691295	0	0	2.4025279533300923	2.5461128046616652	MAPK3
Signaling by Moderate Kinase Activity BRAF Mutants	1/45	0.34653755892445787	0.4305797385691295	0	0	2.4025279533300923	2.5461128046616652	MAPK3
Signaling Downstream of RAS Mutants	1/45	0.34653755892445787	0.4305797385691295	0	0	2.4025279533300923	2.5461128046616652	MAPK3
Infectious Disease	14/1311	0.3500614929567402	0.434274399281239	0	0	1.1485833798598002	1.2056064623391551	PDPK1;SIGMAR1;LY96;CXCR4;NR3C1;MAPK14;NFKB1;NFKB2;NFKBIA;IKBKB;IL1B;TUBB1;LTF;MAPK3
Interleukin-12 Signaling	1/46	0.3526939473641132	0.43548595378761396	0	0	2.3490196078431373	2.448041596261333	CA1
Kidney Development	1/46	0.3526939473641132	0.43548595378761396	0	0	2.3490196078431373	2.448041596261333	FGF2
NIK-->noncanonical NF-kB Signaling	1/46	0.3526939473641132	0.43548595378761396	0	0	2.3490196078431373	2.448041596261333	NFKB2
Cyclin D Associated Events in G1	1/47	0.3587926408833571	0.4409460960388922	0	0	2.297837712159963	2.355308148458001	CKS1B
G1 Phase	1/47	0.3587926408833571	0.4409460960388922	0	0	2.297837712159963	2.355308148458001	CKS1B
Sensory Perception of Taste	1/47	0.3587926408833571	0.4409460960388922	0	0	2.297837712159963	2.355308148458001	SCN2A
Complex IV Assembly	1/48	0.36483417727067946	0.4462855284752963	0	0	2.248833769484583	2.267526834705381	MT-CO2
Defective CFTR Causes Cystic Fibrosis	1/48	0.36483417727067946	0.4462855284752963	0	0	2.248833769484583	2.267526834705381	CFTR
Gap Junction Trafficking	1/48	0.36483417727067946	0.4462855284752963	0	0	2.248833769484583	2.267526834705381	TUBB1
Dectin-1 Mediated Noncanonical NF-kB Signaling	1/49	0.37081908935446795	0.45081088058655655	0	0	2.2018716577540105	2.184346884334174	NFKB2
Pyruvate Metabolism	1/49	0.37081908935446795	0.45081088058655655	0	0	2.2018716577540105	2.184346884334174	GLO1
Signaling by TGFBR3	1/49	0.37081908935446795	0.45081088058655655	0	0	2.2018716577540105	2.184346884334174	FGF2
TP53 Regulates Transcription of Cell Cycle Genes	1/49	0.37081908935446795	0.45081088058655655	0	0	2.2018716577540105	2.184346884334174	TP53
Cell Surface Interactions at the Vascular Wall	3/233	0.37517988642905264	0.4554106621423423	0	0	1.3806345475910693	1.353504624344028	THBD;L1CAM;CD44
SCF(Skp2)-mediated Degradation of P27 P21	1/50	0.37674790511840417	0.45661151634166036	0	0	2.1568263669104004	2.105448610107896	CKS1B
Gap Junction Trafficking and Regulation	1/51	0.3826211474737002	0.4616025769980878	0	0	2.113582887700535	2.030540111295761	TUBB1
IRE1alpha Activates Chaperones	1/51	0.3826211474737002	0.4616025769980878	0	0	2.113582887700535	2.030540111295761	HSPA5
Transcriptional Activity of SMAD2 SMAD3 SMAD4 Heterotrimer	1/51	0.3826211474737002	0.4616025769980878	0	0	2.113582887700535	2.030540111295761	MAPK3
COPI-independent Golgi-to-ER Retrograde Traffic	1/52	0.38843933457323454	0.467906312943942	0	0	2.072035231204781	1.9593543796874393	TUBB1
Bacterial Infection Pathways	2/143	0.3897449392410579	0.4687633491786504	0	0	1.5001143902997025	1.413501919354547	LTF;MAPK3
p53-Dependent G1 DNA Damage Response	1/53	0.3942029797950209	0.47196684530845445	0	0	2.0320855614973263	1.8916467570861657	TP53
p53-Dependent G1 S DNA Damage Checkpoint	1/53	0.3942029797950209	0.47196684530845445	0	0	2.0320855614973263	1.8916467570861657	TP53
Intraflagellar Transport	1/53	0.3942029797950209	0.47196684530845445	0	0	2.0320855614973263	1.8916467570861657	TUBB1
Clathrin-mediated Endocytosis	2/145	0.39637435071978305	0.47384751926955887	0	0	1.4789833822091887	1.3686455783476608	CHRM2;CFTR
Diseases of Glycosylation	2/146	0.3996767690432545	0.4770725730334762	0	0	1.4686379928315412	1.346886634229395	VCAN;NCAN
G1 S DNA Damage Checkpoints	1/55	0.4055686742865402	0.4819181988133738	0	0	1.9566250742721332	1.7657857703512718	TP53
Signaling by Non-Receptor Tyrosine Kinases	1/55	0.4055686742865402	0.4819181988133738	0	0	1.9566250742721332	1.7657857703512718	NR3C1
Signaling by PTK6	1/55	0.4055686742865402	0.4819181988133738	0	0	1.9566250742721332	1.7657857703512718	NR3C1
Interleukin-12 Family Signaling	1/56	0.4111717265659951	0.4858674362797211	0	0	1.9209528439474963	1.7072359397196215	CA1
Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	1/56	0.4111717265659951	0.4858674362797211	0	0	1.9209528439474963	1.7072359397196215	PPARA
Transcriptional Activation of Mitochondrial Biogenesis	1/56	0.4111717265659951	0.4858674362797211	0	0	1.9209528439474963	1.7072359397196215	PPARA
Adaptive Immune System	9/854	0.4113554466854926	0.4858674362797211	0	0	1.1285775676837129	1.0025127498145423	NFKBIA;IKBKB;VCAM1;HSPA5;PDPK1;TUBB1;LY96;NFKB1;ICAM1
Chemokine Receptors Bind Chemokines	1/57	0.4167222431758245	0.4914706276019814	0	0	1.8865546218487395	1.6513679740310914	CXCR4
Signaling by PDGF	1/58	0.4222207141169212	0.49721215438544897	0	0	1.8533633549113426	1.5980200782038276	PLAT
Non-integrin membrane-ECM Interactions	1/59	0.4276676248109873	0.5021276130593288	0	0	1.8213166144200628	1.547042656088635	FGF2
RHOQ GTPase Cycle	1/59	0.4276676248109873	0.5021276130593288	0	0	1.8213166144200628	1.547042656088635	CFTR
ER to Golgi Anterograde Transport	2/155	0.42900612748142575	0.5029507200339449	0	0	1.3816150115960362	1.169238784833907	GRIA1;TUBB1
DNA Damage Telomere Stress Induced Senescence	1/60	0.43306345613115366	0.5062030620555262	0	0	1.790356204114928	1.4982972079494699	TP53
Recruitment and ATM-med Phosphorylation of Repair and Signaling Proteins at DNA Double Strand Breaks	1/60	0.43306345613115366	0.5062030620555262	0	0	1.790356204114928	1.4982972079494699	TP53
DNA Double Strand Break Response	1/61	0.43840868465109334	0.5111790284831985	0	0	1.760427807486631	1.4516553429015628	TP53
Factors Involved in Megakaryocyte Development and Platelet Production	2/158	0.4386162259608687	0.5111790284831985	0	0	1.3548387096774193	1.1165638338415653	TUBB1;TP53
Kinesins	1/62	0.4437037823413914	0.5148268886284674	0	0	1.7314806697641798	1.4069978956615745	TUBB1
RHO GTPases Activate PKNs	1/62	0.4437037823413914	0.5148268886284674	0	0	1.7314806697641798	1.4069978956615745	PDPK1
TP53 Regulates Transcription of DNA Repair Genes	1/62	0.4437037823413914	0.5148268886284674	0	0	1.7314806697641798	1.4069978956615745	TP53
Signaling by TGFB Family Members	2/161	0.44813826118748984	0.5192086462216291	0	0	1.3290728342462974	1.0667849295446559	FGF2;MAPK3
Diseases of Metabolism	3/264	0.4528535936986724	0.5239024713024231	0	0	1.2147250698974836	0.9622886782354351	POMC;VCAN;NCAN
Potential Therapeutics for SARS	2/164	0.4575696406814355	0.5282538396621251	0	0	1.3042612504978097	1.019705598740158	SIGMAR1;NR3C1
ABC Transporter Disorders	1/65	0.4592929455110492	0.5282538396621251	0	0	1.6500668449197862	1.2838626373572537	CFTR
Cytochrome P450 - Arranged by Substrate Type	1/65	0.4592929455110492	0.5282538396621251	0	0	1.6500668449197862	1.2838626373572537	POMC
Signaling by BRAF and RAF1 Fusions	1/65	0.4592929455110492	0.5282538396621251	0	0	1.6500668449197862	1.2838626373572537	MAPK3
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	7/688	0.46991803082706257	0.5396875201201635	0	0	1.0864507021685692	0.8204843130806023	HTR7;PDPK1;C1QBP;TUBB1;MAPK14;CFTR;MAPK3
COPII-mediated Vesicle Transport	1/69	0.47940454546133593	0.5489843053251002	0	0	1.552689525007864	1.1415536039285885	GRIA1
High Laminar Flow Shear Stress Activates Signaling by PIEZO1 and PECAM1 CDH5 KDR in Endothelial Cell	1/69	0.47940454546133593	0.5489843053251002	0	0	1.552689525007864	1.1415536039285885	PDPK1
Metabolism of Proteins	20/2067	0.4807363245152586	0.5497115362935349	0	0	1.03316118826622	0.7567248004629983	GRIA1;NR3C1;ESR1;WARS1;NFKB2;WARS2;NFKBIA;POMC;VCAN;TUBB1;ALB;TRIM13;MT-CO2;PGR;PPARG;PPARA;TP53;CFTR;CES1;LTF
AURKA Activation by TPX2	1/72	0.4939983341562534	0.5640588793766771	0	0	1.4868569707012127	1.0485659326181205	HMMR
Cyclin E Associated Events During G1 S Transition	1/73	0.4987719236575012	0.5678658697918737	0	0	1.4661319073083778	1.0198506713118856	CKS1B
Pre-NOTCH Transcription and Translation	1/73	0.4987719236575012	0.5678658697918737	0	0	1.4661319073083778	1.0198506713118856	TP53
RHOC GTPase Cycle	1/74	0.5035007165125869	0.5724237252571053	0	0	1.4459746538715113	0.9921846361214951	C1QBP
Post-translational Protein Modification	14/1457	0.5061640189706496	0.5744384933225803	0	0	1.0242311276794036	0.6973933559622945	GRIA1;NR3C1;ESR1;NFKB2;NFKBIA;VCAN;TUBB1;ALB;TRIM13;PGR;PPARG;PPARA;TP53;CFTR
Cyclin A Cdk2-associated Events at S Phase Entry	1/75	0.5081851309748556	0.5744384933225803	0	0	1.4263621910680735	0.9655180701334982	CKS1B
Nuclear Envelope (NE) Reassembly	1/75	0.5081851309748556	0.5744384933225803	0	0	1.4263621910680735	0.9655180701334982	TUBB1
Plasma Lipoprotein Assembly, Remodeling, and Clearance	1/75	0.5081851309748556	0.5744384933225803	0	0	1.4263621910680735	0.9655180701334982	ALB
ISG15 Antiviral Mechanism	1/76	0.512825581263391	0.578027690881165	0	0	1.4072727272727272	0.939804153837317	MAPK3
Regulation of mRNA Stability by Proteins That Bind AU-rich Elements	1/76	0.512825581263391	0.578027690881165	0	0	1.4072727272727272	0.939804153837317	MAPK14
G2 M DNA Damage Checkpoint	1/77	0.5174224777833565	0.5823770826976723	0	0	1.3886856177877849	0.9149987967515557	TP53
Costimulation by the CD28 Family	1/78	0.5219762271624845	0.5866655886484334	0	0	1.3705812903673866	0.8910604467265308	PDPK1
Transport to the Golgi and Subsequent Modification	2/186	0.5237656831789599	0.5878394367399706	0	0	1.1470313230481533	0.7417976181665538	GRIA1;TUBB1
RNA Polymerase I Promoter Clearance	1/79	0.5264872323126014	0.59005458280489	0	0	1.3529411764705883	0.8679499146985422	MAPK3
Amyloid Fiber Formation	1/80	0.5309558922193973	0.5942187219306446	0	0	1.3357476477357342	0.8456302142140429	LTF
RNA Polymerase I Transcription	1/81	0.5353826022835901	0.5977150864860314	0	0	1.3189839572192514	0.8240664123068924	MAPK3
Cell Cycle, Mitotic	5/516	0.5355951408689787	0.5977150864860314	0	0	1.031995551420658	0.6443540155307776	TUBB1;HMMR;TP53;CKS1B;MAPK3
Oncogenic MAPK Signaling	1/82	0.5397677543119234	0.6015208448476095	0	0	1.3026341849871261	0.8032254929514189	MAPK3
Asparagine N-linked Glycosylation	3/306	0.5510860453476157	0.6132678276153298	0	0	1.0440995450896442	0.6221416653071158	GRIA1;TUBB1;TRIM13
Transcriptional Regulation by RUNX3	1/86	0.5569004892666548	0.6188654732836488	0	0	1.2410821012897137	0.7264906284288154	TP53
Pre-NOTCH Expression and Processing	1/89	0.5693323408044862	0.6317907410615184	0	0	1.1985901798736023	0.6751549850456123	TP53
ABC-family Proteins Mediated Transport	1/90	0.573398700394607	0.6354095149035744	0	0	1.185062789160608	0.6591011022483088	CFTR
HCMV Early Events	2/205	0.5764345133627986	0.637877743398665	0	0	1.0386673022935538	0.5721951062100253	TUBB1;NFKB1
Scavenging of Heme From Plasma	1/92	0.5814171993211176	0.6424904345439241	0	0	1.158899923605806	0.6284560252840122	ALB
Recruitment of NuMA to Mitotic Centrosomes	1/94	0.5892857667721465	0.6493665781888598	0	0	1.1338623425909953	0.599636342287352	TUBB1
Signaling by TGF-beta Receptor Complex	1/94	0.5892857667721465	0.6493665781888598	0	0	1.1338623425909953	0.599636342287352	MAPK3
Phospholipid Metabolism	2/211	0.5921650964050371	0.6509136968229347	0	0	1.0085404126151154	0.5284447222384023	PLA2G2E;PLA2G2A
Role of LAT2 NTAL LAB on Calcium Mobilization	1/95	0.5931646996396578	0.6509136968229347	0	0	1.1217430879508477	0.585867545829172	PDPK1
Unfolded Protein Response (UPR)	1/95	0.5931646996396578	0.6509136968229347	0	0	1.1217430879508477	0.585867545829172	HSPA5
Mitochondrial Protein Degradation	1/97	0.6008135825429668	0.6583915508700012	0	0	1.0982620320855614	0.5595321849889476	MT-CO2
Signaling by Rho GTPases	6/672	0.6081188942596782	0.6647701024412135	0	0	0.9477279477279478	0.471385538630213	PDPK1;C1QBP;TUBB1;MAPK14;CFTR;MAPK3
Hedgehog 'Off' State	1/99	0.6083194093315034	0.6647701024412135	0	0	1.0757393866637563	0.5347018459447976	TUBB1
SARS-CoV-2-host Interactions	2/218	0.6099655182016144	0.6656470177884837	0	0	0.9755077658303465	0.4822450451629345	IKBKB;PDPK1
COPI-dependent Golgi-to-ER Retrograde Traffic	1/101	0.6156848414284363	0.6700349515683257	0	0	1.0541176470588236	0.5112682122546338	TUBB1
COPI-mediated Anterograde Transport	1/101	0.6156848414284363	0.6700349515683257	0	0	1.0541176470588236	0.5112682122546338	TUBB1
Immunoregulatory Interactions Between a Lymphoid and a non-Lymphoid Cell	2/223	0.622316344942801	0.6741810090416621	0	0	0.9531941808981658	0.45210640773063127	VCAM1;ICAM1
Epigenetic Regulation of Adipogenesis Genes by MLL3 and MLL4 Complexes	1/103	0.6229124912438171	0.6741810090416621	0	0	1.033343818810947	0.489132504631589	PPARG
Epigenetic Regulation of Gene Expression by MLL3 and MLL4 Complexes	1/103	0.6229124912438171	0.6741810090416621	0	0	1.033343818810947	0.489132504631589	PPARG
MLL4 and MLL3 Complexes Regulate Expression of PPARG Targets in Adipogenesis and Hepatic Steatosis	1/103	0.6229124912438171	0.6741810090416621	0	0	1.033343818810947	0.489132504631589	PPARG
Viral Infection Pathways	9/1029	0.6353844661224958	0.6867374572200674	0	0	0.9263227078540913	0.4201105105674181	NFKBIA;IKBKB;PDPK1;TUBB1;SIGMAR1;LY96;CXCR4;NR3C1;NFKB1
Transport of Inorganic Cations Anions and Amino Acids Oligopeptides	1/107	0.6369646519305451	0.68750357096197	0	0	0.9941479164564625	0.4484015861296075	SLC15A1
Maternal to Zygotic Transition (MZT)	1/109	0.6437941492042452	0.6929789682430415	0	0	0.9756387403446227	0.42964812794239593	TP53
RSV-host Interactions	1/109	0.6437941492042452	0.6929789682430415	0	0	0.9756387403446227	0.42964812794239593	LY96
FCERI Mediated MAPK Activation	1/111	0.6504958384172262	0.6973386093902058	0	0	0.9578026251823043	0.4118746474704044	MAPK3
Mitotic Prophase	1/111	0.6504958384172262	0.6973386093902058	0	0	0.9578026251823043	0.4118746474704044	MAPK3
Phase II - Conjugation of Compounds	1/111	0.6504958384172262	0.6973386093902058	0	0	0.9578026251823043	0.4118746474704044	GSTP1
Chromatin Modifying Enzymes	2/238	0.6575619395926675	0.7030032118409413	0	0	0.8919263714233643	0.3739100863793132	NFKB1;NFKB2
Chromatin Organization	2/238	0.6575619395926675	0.7030032118409413	0	0	0.8919263714233643	0.3739100863793132	NFKB1;NFKB2
EML4 and NUDC in Mitotic Spindle Formation	1/116	0.6667064074594853	0.7118150953796128	0	0	0.9159265287142525	0.37132165114194304	TUBB1
G1 S Transition	1/121	0.6821689141030982	0.7273395584153305	0	0	0.8775401069518717	0.33563976498986536	CKS1B
Class I MHC Mediated Antigen Processing & Presentation	3/373	0.6842166322156651	0.7285383573794328	0	0	0.8520964207450694	0.32335414428371984	IKBKB;HSPA5;LY96
MHC Class II Antigen Presentation	1/126	0.6969177029925805	0.7400646940257685	0	0	0.8422245989304813	0.30411715249807125	TUBB1
Resolution of Sister Chromatid Cohesion	1/126	0.6969177029925805	0.7400646940257685	0	0	0.8422245989304813	0.30411715249807125	TUBB1
Metabolism of Water-Soluble Vitamins and Cofactors	1/127	0.6997847257138966	0.7411142934070664	0	0	0.8354978354978355	0.2982581277264498	PTGS2
Reproduction	1/127	0.6997847257138966	0.7411142934070664	0	0	0.8354978354978355	0.2982581277264498	CXCR4
HCMV Infection	2/259	0.7024468412066651	0.7429364044397571	0	0	0.8181666039077863	0.28896462323446453	TUBB1;NFKB1
Aerobic Respiration and Respiratory Electron Transport	2/260	0.7044578536399979	0.7440659257322066	0	0	0.8149537384346086	0.2855001140901141	GLO1;MT-CO2
Respiratory Syncytial Virus Infection Pathway	1/133	0.7164290795523819	0.7556985879235687	0	0	0.797277588721439	0.2658729558432434	LY96
Epigenetic Regulation by WDR5-containing Histone Modifying Complexes	1/135	0.7217706160973232	0.7593026881343841	0	0	0.7852981083885386	0.25604479660504653	PPARG
Golgi-to-ER Retrograde Transport	1/135	0.7217706160973232	0.7593026881343841	0	0	0.7852981083885386	0.25604479660504653	TUBB1
Signaling by Hedgehog	1/136	0.7244037323179093	0.761057982421878	0	0	0.7794414735591206	0.2512969200445409	TUBB1
G2 M Checkpoints	1/137	0.7270120603256971	0.7627826005278923	0	0	0.7736709657124882	0.24665575226193928	TP53
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses	1/138	0.7295958321236871	0.7644769077630665	0	0	0.7679846988563176	0.24211835263304302	IKBKB
Mitotic G1 Phase and G1 S Transition	1/139	0.7321552778399212	0.7651265088949639	0	0	0.7623808416647291	0.23768187861218082	CKS1B
RHO GTPases Activate Formins	1/139	0.7321552778399212	0.7651265088949639	0	0	0.7623808416647291	0.23768187861218082	TUBB1
Cell Cycle	5/649	0.7339380324645989	0.7657475604942999	0	0	0.8132233648983471	0.2515549351276692	TUBB1;HMMR;TP53;CKS1B;MAPK3
Degradation of the Extracellular Matrix	1/140	0.7346906252144297	0.7657475604942999	0	0	0.7568576155118686	0.23334358238543715	CD44
FCGR3A-mediated Phagocytosis	1/142	0.7396899255787375	0.7679149358968735	0	0	0.7460461941062692	0.22495098190458354	MAPK3
Leishmania Phagocytosis	1/142	0.7396899255787375	0.7679149358968735	0	0	0.7460461941062692	0.22495098190458354	MAPK3
Parasite Infection	1/142	0.7396899255787375	0.7679149358968735	0	0	0.7460461941062692	0.22495098190458354	MAPK3
Regulation of Actin Dynamics for Phagocytic Cup Formation	1/143	0.742154323667133	0.7694609216470013	0	0	0.7407546885591625	0.22089162148030606	MAPK3
tRNA Processing	1/146	0.7494091370174478	0.7759630040771212	0	0	0.7253180896182925	0.20923265455930626	MT-CO2
RHOA GTPase Cycle	1/149	0.7564608807259995	0.7822380535947753	0	0	0.7105072987425929	0.19830575449352322	C1QBP
S Phase	1/150	0.7587673172497141	0.7835960907199273	0	0	0.7057029034920863	0.1948164236180263	CKS1B
DNA Double-Strand Break Repair	1/152	0.7633152094235587	0.7872623532486116	0	0	0.6962850161136098	0.18805559164312785	TP53
HIV Life Cycle	1/158	0.7764534613992506	0.7984231449538938	0	0	0.6694710310296672	0.16938860426381644	CXCR4
Respiratory Electron Transport	1/158	0.7764534613992506	0.7984231449538938	0	0	0.6694710310296672	0.16938860426381644	MT-CO2
Anti-inflammatory Response Favouring Leishmania Parasite Infection	1/159	0.778571516972799	0.7984231449538938	0	0	0.6652000270764232	0.16649585950913168	MAPK14
Leishmania Parasite Growth and Survival	1/159	0.778571516972799	0.7984231449538938	0	0	0.6652000270764232	0.16649585950913168	MAPK14
Translation	2/302	0.7791962251134325	0.7984231449538938	0	0	0.6993548387096774	0.17448369704259775	WARS1;WARS2
SARS-CoV-2 Infection	2/313	0.7958347871567105	0.8143029822953314	0	0	0.6742384953151471	0.15397157623628346	IKBKB;PDPK1
Fcgamma Receptor (FCGR) Dependent Phagocytosis	1/168	0.7967577976324408	0.8143029822953314	0	0	0.629062730154664	0.142925907564824	MAPK3
Separation of Sister Chromatids	1/177	0.813457686998682	0.8302951035471671	0	0	0.5966212931453573	0.12317924788296555	TUBB1
Cilium Assembly	1/200	0.8501901851438446	0.8666667391195005	0	0	0.5270469997044044	0.08553720207249918	TUBB1
Transcriptional Regulation by RUNX1	1/202	0.8530215909541496	0.8684310132423536	0	0	0.5217495410647298	0.08294274369038149	ESR1
Mitotic Prometaphase	1/203	0.8544172681402742	0.868730959487985	0	0	0.5191401493090485	0.08167922694940219	TUBB1
Intra-Golgi and Retrograde Golgi-to-ER Traffic	1/204	0.8557997617950049	0.8690167465331518	0	0	0.5165564658465267	0.08043758054768439	TUBB1
Signaling by NOTCH	1/209	0.8625187737848429	0.874713769301081	0	0	0.5040106951871658	0.07454235705833076	TP53
Signaling by ROBO Receptors	1/210	0.8638247280006909	0.874913620529583	0	0	0.501573574188266	0.07342304420792746	CXCR4
M Phase	2/372	0.8674771829234026	0.8774865350340572	0	0	0.5650101714617843	0.0803252753678727	TUBB1;MAPK3
Mitotic Anaphase	1/221	0.8774007540097591	0.8863882137179256	0	0	0.4762275157997083	0.062286478216861355	TUBB1
Mitotic Metaphase and Anaphase	1/222	0.8785660463825182	0.8864304483322338	0	0	0.4740484429065744	0.061372299257554205	TUBB1
HIV Infection	1/227	0.8842292989692598	0.8910050024096373	0	0	0.46344233590459516	0.05702141761485451	CXCR4
rRNA Processing	1/237	0.8947795962112967	0.9004860987381546	0	0	0.4435783558415662	0.04931608890748734	MT-CO2
Cell Cycle Checkpoints	1/261	0.9163593665117659	0.9210287136022717	0	0	0.4021390374331551	0.03512550568683728	TP53
RHO GTPase Cycle	2/450	0.9270495336039576	0.930587890602446	0	0	0.4647657450076805	0.03520520603607079	C1QBP;CFTR
Epigenetic Regulation of Gene Expression	1/291	0.9372456926914521	0.9396275114784698	0	0	0.3599852480177024	0.023330578789968196	PPARG
DNA Repair	1/312	0.94869152492268	0.9498954481776581	0	0	0.33531647093213196	0.01766165032982411	TP53
Metabolism of RNA	3/761	0.976011212834971	0.976011212834971	0	0	0.4076303216144905	0.009897755026122963	MT-CO2;MAPK14;CD44
